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ABSTRACT
Although the prevalence of malnutrition in the old age is increasing worldwide a 
synthetic understanding of the impact of aging on the intake, digestion, and absorption 
of nutrients is still lacking. This review article aims at filling the gap in knowledge 
between the functional decline of the aging gastrointestinal tract (GIT) and the 
consequences of malnutrition on the health status of elderly. Changes in the aging 
GIT include the mechanical disintegration of food, gastrointestinal motor function, 
food transit, chemical food digestion, and functionality of the intestinal wall. These 
alterations progressively decrease the ability of the GIT to provide the aging organism 
with adequate levels of nutrients, what contributes to the development of malnutrition. 
Malnutrition, in turn, increases the risks for the development of a range of pathologies 
associated with most organ systems, in particular the nervous-, muscoskeletal-, 
cardiovascular-, immune-, and skin systems. In addition to psychological, economics, 
and societal factors, dietary solutions preventing malnutrition should thus propose 
dietary guidelines and food products that integrate knowledge on the functionality of 
the aging GIT and the nutritional status of the elderly. Achieving this goal will request 
the identification, validation, and correlative analysis of biomarkers of food intake, 
nutrient bioavailability, and malnutrition.
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EFFECT OF THE AGING PROCESS ON 
THE NUTRITIONAL STATUS
The aging human organism
What does “old“ mean?
A first attempt to internationally define age was 
made by the World Health Organization (WHO) and 
United Nations declaring that “old age” is denoted by the 
age of 60–65 y in the developed world [1]. In particular, 
different gerontology experts defined further sub-groups 
of this population segment such as Forman et al. [2] who 
categorized generation 60+ in the “young old” (60–69 y), 
the “middle old” (70–79 y), and the “very old” (80 + y) 
persons or Zizza et al. [3] who divided the elderly in 
the three categories of “young olds” (65–74 y), “middle 
olds” (75–84 y), and “oldest olds” (85+ y). However, the 
population group of old humans is very heterogeneous and 
chronological age alone does not necessarily determine 
the physiological condition the aging organism consists 
of. It is, indeed, the biological age that pictures the face of 
aging. Every organism is growing old differently and the 
individual perception of this process differs depending on 
the attitude, living conditions, diseases and environmental 
influences [4]. Contingent on the state of physiological 
and psychological condition of the aging organism, 
elderly may live in different settings including acute care 
(hospitals), sub-acute/rehabilitation care, institutions such 
as nursing homes, long-term care or sheltered housing, 
as well as home care and free/independent living in the 
community [5].
Demographic development in Europe
The latest Demographic Report launched by the 
European Commission and Eurostat in 2010 starts with the 
words: “Older, more numerous and diverse Europeans” 
and highlights three main trends characterizing the current 
European demographic development: i) insufficient 
fertility, despite a slight increase, ii) longer life expectancy, 
and iii) important migration.
The age structure of populations in Europe is 
becoming older and this process will continue in future 
decades. In January 2010, the European population 
aged 65 y or over accounted for 17.4%. Germany had 
the largest proportion of this age group (20.7%), closely 
followed by Italy (20.2%), whereas the lowest proportion 
was found in Ireland (11.3%), Slovakia (12.3%), and 
Cyprus (13.1%). Figure 1 illustrates the structure of the 
European population by sex and by five-year age groups. 
The population pyramid of 2010 is narrow at the base 
and becomes more rhomboid in direction to the top. This 
structure is due to very high fertility rates in the mid-60ies, 
a time in which the baby boomer cohorts were born. The 
first of these large cohorts will soon reach retirement age. 
Figure 1: Age structure of the European population by gender and by five-year age groups [6]. Each bar corresponds to 
the proportion of the given sex and age group to the total population. Empty bars: populations observed in 2010; filled bars: convergence 
scenario for 2060; blue bars (left): men; orange bars (right): women.
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Furthermore, also the top of the pyramid is getting wider 
since longevity is increasing due to many factors such as 
medical progress or better supply of nutrients.
The estimated change in age structure is of higher 
concern than the change in population size. The proportion 
of the population group 65 y and older is projected to 
increase from 17.4% in 2010 to 30.0% in 2060 whereas 
most of the increase is expected to occur between 2020 
and 2040. Moreover, the segment of people aged 80 y or 
over is growing faster than any other age group and is 
projected to triple by 2060. These numbers are causative 
of the many challenges facing the social system, health 
care, and politics. Time of action must be now in order to 
prevent these systems from collapsing [6].
The many faces of aging
All organs and physiological processes of the 
human organism are affected by aging including, 
inter alia, 1) body composition with a loss of fat-free mass 
(in particular skeletal muscle tissue, which is known as 
sarcopenia) and an increase in fat mass and its distribution 
[7], 2) brain function [8] with its worst outcomes dementia 
and Alzheimer’s disease, 3) GIT function [4] with a 
reduction in sensory perceptions, salivation, oral health, 
the absorption of nutrients, and lactose tolerance, 4) fluid 
balance characterized by an exceedance of fluid output 
[9], 5) bones and joints [10] with osteoporosis and arthritis 
entailing falls and fractures, 6) metabolism including 
e.g. diabetes mellitus type 2 [11] and dyslipidemia [12], 7) 
cell growth with cancer [13], and 8) the cardiovascular 
system [14]. However, aging faces many changes and is 
not only limited to physiological restrictions as social, 
psychological and economic factors also strongly influence 
the aging process. All of these factors are currently the 
focus of intense research on their own. An understanding 
of their interactions, and a deeper knowledge of the aging 
consumer are clearly of upmost importance for the early 
identification and treatment of nutrition problems, that in 
turn can lead to improved outcomes and better quality of 
life in elderly people [15].
The aging consumer
A large number of studies has been conducted that 
investigated the food consumption behavior of elderly. 
In particular, these studies showed that elderly feel less 
hungry [16], snack less often between the main meals 
[17], and have less cravings for food in comparison to 
their younger counterparts [18]. Many of these changes 
are related to modifications of peripheral hormones 
including cholecystokinin (CCK), leptin, ghrelin, insulin, 
and peptide YY (PYY). These hormones are released 
during food ingestion and play a crucial role by affecting, 
on the one hand, the activity in the key brain areas, which 
in turn control food intake [19] and, on the other hand, 
parts of the GIT [20]. The mechanisms by which these 
hormones influence food intake, satiety, and hunger are 
reviewed elsewhere [20]. However, other physiological 
factors influence food intake in elderly, in particular 1) 
edentulism and dental problems that impact on both oral 
function and social interactions [21], 2) xerostomia (“dry 
mouth syndrome”), which changes the perception of taste 
and smell and promotes caries and infections in the mouth 
[22, 23], 3) a reduction of olfactory, gustatory, and visual 
food perception leading to a decrease in appetite, a lower 
diversity in meal composition and food choices [20], 4) a 
reduction of fluid intake, which is often due to a diminished 
thirst sensation but also to anxiety about incontinence and 
toileting assistance and which may lead to cognitive and 
physical impairments or, in the worst case, to an increased 
mortality risk [9], and 5) changes in central brain control, 
i.e. in the hypothalamus, which controls hunger and satiety 
as well as the activity of important neurotransmitters 
and neuropeptides including serotonin, dopamine and 
opioids [24]. In addition to these physiological changes, 
psychological and social factors also contribute to an 
alteration of food intake during aging. The psychological 
factors include 1) depression, which is a common disorder 
in elderly frequently accompanied by a loss of appetite 
and a decrease in food consumption [25], 2) apathy, 
characterized by a lack of interest and emotions, which 
can occur as an independent disorder or as a symptom of 
depression or cognitive decline, and which reduces the 
motivation to eat and drink [20], and 3) mood, a positive or 
negative emotional status, which strongly influences food 
intake [26]. Finally, a strong contribution to changes in 
eating behavior is also attributed to social factors including 
loneliness, social isolation, widowhood, poverty, and a 
change of environment such as housing (nursing home, 
hospital, free-living…). These social changes may impact 
negatively on the eating habits of elderly and meals are 
consequently prepared less frequently, with significantly 
less diversity in their composition, and with a lost in the 
pleasure of eating [25]. This list is not exhaustive and 
other factors, such as income, education, diet-related 
attitudes and beliefs, convenience, a decreased mobility 
and dexterity that render the shopping and cooking 
more difficult, likely play a role as well in the onset of 
malnutrition in the elderly [27].
In summary, the aging consumer, in particular if 
their health status is weakened, is influenced by many 
factors whose relationships are not yet fully understood. 
The occurrence of already a few of these factors may 
therefore impact on the others and strongly increase the 
risk of malnutrition.
Malnutrition in aging
Definition and causes of malnutrition
Malnutrition is one of the most relevant conditions 
that negatively influence the health of older people and 
the nutritional status of elderly (65 + y) was even recently 
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shown to predict preterm death [28]. Although aging 
is not inevitably accompanied by malnutrition, many 
changes due to the aging process can promote this serious 
condition [29].
Since there is no official definition of the term 
“malnutrition”, different organizations and groups 
working in this field described malnutrition as the state 
of being poorly nourished, due to a lack of one or more 
nutrients (undernutrition) or an excess of nutrients 
(overnutrition) [30]. WHO states that malnutrition is 
the cellular imbalance between supply of nutrients and 
energy and the body’s demand for them to ensure growth, 
maintenance, and specific functions [31]. However, the 
main concern is rather undernutrition than overnutrition 
because its relation to morbidity and mortality is much 
stronger than that of obesity [32]. Therefore, literature 
mainly refers to undernutrition when addressing the topic 
of malnutrition.
The main cause for malnutrition is a reduced and/or 
unbalanced dietary intake. However, this reduced intake 
can be due to many factors that are again divided in three 
main categories: social, physiological, and psychological. 
Examples for each category are summarized in Table 1 
[30, 33, 34].
Screening tests for malnutrition
Many attempts have been made in order to develop 
efficient nutritional screening and assessment tools 
that detect malnutrition in humans living in a variety of 
settings. The establishment of these tools is critical in 
order to diagnose in an early stage and, eventually, prevent 
malnutrition. The parameters that are essential components 
of malnutrition screening include a reduced dietary intake, 
weight loss, a reduced nutritional status, and the existence 
of diseases [35]. A variety of screening tests have been 
Table 1: Causes of malnutrition 
Social factors
 Lack of knowledge about food, cooking, and nutrition
 Isolation/loneliness
 Poverty
 Inability to shop and/or prepare food
 Inability to prepare food
Physiological factors
 Gastrointestinal dysfunction, e.g. malabsorption
 Poor appetite and poor diet
 Oral problems such as teeth loss and dysphagia
 Loss of taste and smell
 Respiratory disorders
 Endocrine disorders, e.g. diabetes mellitus type 2
 Neurological disorders, e.g. Parkinson disease
 Infections, e.g. urinary tract infections
 Physical disability to feed self
 Drug interactions
 Nausea and vomiting
 Altered/increased metabolic demands
 Other diseases, e.g. cancer
Psychological factors
 Dementia
 Depression
 Confusion
 Anxiety
Note: see references [30,33,34]
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developed among these the Nutritional Screening Index, 
SCREEN, the Appetite, Hunger and Sensory Perception 
Questionnaire (AHSP), the Malnutrition Universal 
Screening Tool (MUST), and the Saint Louis University 
SCALES nutritional index. The screening of malnutrition 
also includes a range of anthropometric parameters such 
as BMI, arm span, waist circumference, or mid-arm 
circumference measurements. Each of these tests varies 
with regard to the type of data collected, their specificity 
and their sensitivity. Importantly, no single test is available 
that optimally detects malnutrition in a broad range of 
health conditions (healthy vs non-healthy elderly) and 
housing settings [36].
The most frequently used tool for determination of 
the nutritional status in aged people is the mini nutritional 
assessment (MNA) [5]. MNA was first developed by 
Vellas and Guigoz approx. 20 years ago [37] to be then 
continuously improved over the years. MNA is currently 
the gold standard of nutritional assessment since it is 
adapted to the older age group, relatively easy to use, 
and highly sensitive [5]. MNA consists of 18 questions 
grouped in four categories: anthropometry, general 
status, dietary habits, and self-perceived health and 
nutrition states. The summation of the scores awarded 
to the different questions (maximum 30 points) allows 
a grading of the nutritional status (score > 24 points: 
good status, 17 < score < 24 points: risk of malnutrition; 
score < 17 points: malnutrition). A shorter form of 
MNA, MNA short form (MNA-SF), was developed 
in 2001 [37] and validated in 2009 [38]. MNA-SF also 
divides the nutritional status in three categories but the 
time for completion is significantly reduced and the 
scoring is independent of BMI. However, due to its low 
specificity, MNA has been associated with a high risk of 
“overdiagnosis” [5]. Consequently, experts recommend, 
particularly for unclear cases, to complement MNA with 
other screening tools. These experts also advocate the need 
for further research in that field [5].
Prevalence of malnutrition and impact on costs
Malnutrition occurs in all residential and living 
settings [39]. The estimates of its prevalence are highly 
variable due to the use of different evaluation tools and 
different settings. Previous publications reported prevalence 
ranging from “almost non-existing” in healthy, community-
living “young elderly” [40] to 57% in persons living in 
long-term care institutions [41]. Furthermore, the prevalence 
differs between rural (7.4% malnourished) and urban (18.5% 
malnourished) living individuals [42]. In 2010, Kaiser et al. 
[39] published a review that more precisely determined 
malnutrition among older adults (65 y and older). The 
reviewed studies were selected from the literature if 
MNA was used and if the setting (community-dwelling, 
nursing home, hospital, geriatric rehabilitation) was clearly 
described. The effective sample size was 4,507 (24 studies 
from 12 countries, mainly of European origin) with an 
average age of 82.3 y. In total, 46.2% of the participants 
were at risk of malnutrition and 22.8% were malnourished. 
When only focusing on the two groups of elderly that were 
hospitalized or in geriatric rehabilitation, approx. 90% of 
them were malnourished or at risk of malnutrition. In the 
nursing home setting, only one third of participants were 
well nourished. Furthermore, 31.9% of elderly living 
in the community were at risk of malnutrition whereas 
only a small fraction was malnourished. Another review 
published in 2011 investigated the worldwide prevalence 
of malnutrition and the risk of malnutrition in the elderly 
population [5]. For this analysis, the data was extracted from 
published and unpublished studies in which the nutritional 
status was measured with MNA or with a validated MNA-
SF and the living setting was clearly defined. Among the 
elderly treated in acute care in hospitals (n = 17,775), 
23.4% were malnourished and 49.4% were at risk of 
malnutrition. In subacute rehabilitation care (n = 3,724) 
malnutrition occurred in 31.0% of the individuals and 
54.0% were at risk of malnutrition. In institutions, such 
as nursing homes, long-term care and sheltered housing 
(n = 20,410), 27.2% were malnourished and 52.1% were at 
risk of malnutrition. Also, 7.7% of elderly in home care or 
outpatients (n = 12,386) were malnourished and 39.6% were 
at risk of malnutrition. Finally, only 4.2% of community-
dwelling elderly (n = 50,957) were malnourished and 27.4% 
were at risk of malnutrition. Of note, three of the reviewed 
studies were conducted in rural communities of developing 
countries, which reported significantly higher prevalence of 
malnutrition and elderly at risk of malnutrition.
In a review from the British Association for 
Parenteral and Enteral Nutrition (BAPEN) meeting held 
in 2013 malnutrition was reported to cost £ 7.3 billion 
per year in Britain. Malnutrition affects 10% of the 
population over the age of 65 y and over half of the 
health care costs is in this age group [43]. Using a 
multivariate logistic regression model Isabel et al. [44] 
concluded that malnutrition is an independent risk factor 
for a range of hospital parameters including length of 
hospital stay, complications, mortality, and costs. This 
analysis showed that malnourished patients represented 
a mean daily expense of US$ 228 compared to US$ 138 
per well-nourished patient (increase of 60% in costs 
due to malnutrition). When the costs of medications 
and tests were added the costs of the malnourished 
patients rose by 309% compared to the well-nourished 
patients. Of note, the actual costs may vary between 
countries due to differences in health systems. In a study 
performed by Ben-Gurion University, the number of 
hospitalization days was doubled in elderly patients at 
risk of malnutrition when compared to elderly patients 
with a normal nutritional status. Also, significantly higher 
rates of readmission were observed in elderly patients 
at risk of malnutrition following discharge from acute 
hospitalization [45].
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Strategies to prevent and treat malnutrition
Strategies that aim at treating or even preventing 
malnutrition in elderly are subject to intense research 
activity. The multifactorial character of malnutrition in 
aged people demands the development of holistic dietary 
strategies and recommendations including 1) social 
interferences aiming at the avoiding and revoking of social 
isolation as well as a monitoring of the living standard 
of the elderly by family members and friends, 2) the 
administration of nutritional supplements, 3) an 
improvement of the quality of care settings, and 4) in 
worst cases, clinical interventions. However, the core 
of the multi-disciplinary strategy to prevent and treat 
malnutrition in the elderly is undoubtedly the dietary 
intervention as advocated by the “first food policy” whose 
major objective is to ensure adequate supply of food to all 
[46, 47]. To be successful, the intervention requires more 
detailed evidence-based dietary recommendations for 
elderly and novel food products, which suit the needs and 
requirements of elderly. The fourth part of this review will 
present this topic in detail.
Malnutrition affects the function and recovery of 
every organ system in humans: it impairs liver, gut and 
renal function, wound healing, decreases immunity and 
muscle strength as well as cardiac output, and moreover 
may cause depression and apathy [33]. A poor nutritional 
status is a major negative prognostic indicator in the 
elderly population [48, 49]. Regardless of BMI or weight 
loss caused by undernutrition in persons aged 60 + y 
malnutrition is also associated with increased mortality 
[36]. Furthermore, malnutrition is associated with longer 
hospital stays, re-admission, immune dysfunction, high 
demands on medical services, and early institutionalization. 
Moreover, a higher risk of chronic disability such as frailty 
and poor quality of life are further serious consequences of 
malnutrition, more precisely undernutrition [34]. Finally, 
malnutrition has emerged as an important factor in the 
development of sarcopenia and dementia [50]. The third 
part of this review will present this topic in detail.
Malnutrition increases the risk for frailty in elderly, 
and in turn the aging process increases the risk of 
malnutrition. To break down this negative loop, with the 
final aim of maintaining good health and a high quality 
of life in the ageing population by providing them a 
balanced diet taking into account their nutritional needs, 
an in depth analysis of the impact of age-related changes 
on the nutritional status is needed. In the past, research 
focused on the cognitive decline as well as on the changes 
taking place in body composition and organ function as 
age progresses. Although the GIT is crucial for the release 
and delivering of nutrients from foods to the human body 
an exhaustive analysis of phenomena occurring in the 
GIT during aging and on their impact on malnutrition has 
never been conducted. The second part of this review will 
address this particular point.
THE AGING GASTROINTESTINAL 
TRACT
Effect of aging on GIT functions
Chewing activity
The mechanical and chemical processes of digestion 
start in the mouth, with mastication. This first step is needed 
for the mechanical breakdown of food into smaller particles 
and is assisted by saliva secretion for fragments lubrication, 
moistening, and initiation of oral digestion. A large contact 
area between food and saliva is important in order to form 
a cohesive food bolus ready to be swallowed. Saliva also 
initiates digestion through the action of salivary enzymes, 
such as alpha-amylases or lipases, which help break down 
the chemical bonds in food constituents [51]. The two actions 
of mastication and salivation, under a permanent adjustment 
of the masticatory forces to the food properties [52], 
coordinate to form a bolus whose consistency progressively 
reaches the structural properties needed to ensure a safe-
swallowing. Apart from food structural disruption, chewing 
also participates in the release of sensory signals involved in 
taste perception.
The main age-related changes in the oral sphere are a 
decrease in bite force and mandibular reflex occurrences, a 
decrease in the number of oro-sensory receptors (mechano- 
and gustative receptors) leading to an increase in sensory 
thresholds, and a decline in saliva secretions [53, 54]. Motor 
activity of tongue and masticatory muscles also declines.
Masticatory function in elderly depends on two 
major factors, which are the number of natural antagonist 
teeth and the quantity and quality of saliva. Subsequent 
potential nutritional consequences are generally 
considered according to two different viewpoints [55, 56].
The first viewpoint considers a healthy oral aging 
taking place without any important oral disorders such as 
tooth loss or critical saliva deficiency. For this segment of 
population, aging is associated with a decrease in maximal 
bite force [57] and changes in masticatory muscle tissue 
[58, 59]. However, these alterations have little impact on 
masticatory performance as these persons still produce 
a food bolus suitable for swallowing and only minor 
adaptations are needed to compensate the physiological 
changes [60, 61]. In particular, the number of masticatory 
cycles needed to form the food bolus increases with age 
(three additional masticatory cycles every ten years) [62]. 
Consequently, the masticatory process before swallowing 
is lengthened and the total masticatory muscle contraction 
is increased without altering the resulting food breakdown 
[55, 62–64]. Concerning swallowing, which ends the 
masticatory process, the major change occurring with age 
under healthy conditions appears to involve modifications 
in the temporal cascade of events to adapt to a slight 
decrease in oral perception of viscosity, rather than to 
adapt to a decrease in swallowing reflex [65, 66].
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The second viewpoint considers the impact of 
oral functioning on digestion or nutritional status in the 
elderly [67]. Elderly with a good oral health maintain 
their potential of adaptation of masticatory parameters 
with little or no consequences on subsequent digestion. 
Another segment of the elderly population suffers, 
however, from poor oral health, which is characterized by 
a high prevalence of tooth loss and oral disorders related 
or not to other systemic diseases. In this population group, 
adaptation of the oral process becomes less efficient, even 
fails, and finally leads to an impaired function. Elderly 
tend to have fewer natural teeth and higher rates of tooth 
loss until edentulism [68]. Tooth loss causes impaired 
mastication and tissue alterations in the mandibular bone, 
and the level of resulting impairment is linked to the 
number of remaining teeth [69]. The degree of food size 
reduction, reflecting chewing efficiency or performance, 
is greatly reduced in denture wearers in a gradual manner 
depending on the number of teeth lost [55, 70]. Numerous 
studies showed that elderly with a compromised dentition 
fail to prepare a food bolus that is ready for swallowing 
because an insufficient disruption of the bolus is 
associated with a greater proportion of large particles 
[55, 63, 71, 72]. A median value of 4 mm particle size of 
a bolus of raw carrot defines the swallowing threshold, 
which is used to conclude if mastication is correct or 
not [73]. The consequences of an insufficient disruption 
of the food bolus are worsened if this phenomenon is 
accompanied by a lack in saliva, as frequently observed 
in the elderly, especially those under medication, 
which is known to affect salivation [74]. Apart from an 
insufficient breakdown of food, scarcity of saliva during 
bolus formation also increases the risk of dysphagia and 
aspiration of food fragments, impairs early digestion and 
the dissolution of nutrients [75]. In addition, denture 
wearers fail to adapt to changes in food texture such as 
hardness [55]. Importantly, an impaired oral health often 
leads elderly to modify their diet to adjust it to their 
limited oral functional capacities [76]. These changes 
are mostly not adequate to maintain good overall health 
since soft foods are often foods rich in fat and contain 
additives [77].
Masticatory deficiency seems to be a risk factor 
for cognitive dysfunction [78]. Although a clear causal 
evidence between malnutrition and poor oral health in the 
elderly population is still missing, it appears evident that 
elderly suffering from oral problems are exposed to an 
increased risk of malnutrition, either by avoiding nutritious 
food being difficult to chew or by swallowing food boli 
that are insufficiently disrupted for a thorough assimilation 
of the nutrients [75, 79, 80]. Based on a systematic review 
of several published works, van Lancker et al. [81] found 
an association between malnutrition and the oral health 
status, although the main cause of malnutrition was a 
reduced intake of foods of good quality. Future research is 
needed to investigate if causal relationship exists.
Meanwhile, some oral health indicators must be 
included into nutritional studies in the elderly population. 
As already suggested by Hatch et al. [82], the number 
of functional units is a key predictor of masticatory 
performance. In the same line, El Osta et al. [83] proposed 
to consider the perception of xerostomia, the number 
of functional units present in the mouth, and the score 
obtained with the Geriatric Oral Health Assessment 
Index (GOHAI) [84] as the most appropriate oral health 
indicator. Such an evaluation of oral health could be 
combined with the MNA to reliably identify elderly at high 
risk of malnutrition [85].
Food transit in the different GIT segments, and 
motor activity
Food transit
Stomach
Gastric emptying plays a key role in the kinetics 
of nutrient absorption, which in turn regulates nutrient 
utilization in body functions. This is clearly illustrated by 
the concept of slow/fast carbohydrates and proteins and 
their respective effects on glucose and protein homeostasis. 
Mechanisms involved in food disintegration and gastric 
emptying have been well described in the review of Kong 
and Singh [86]. Liquid and solid meals display different 
gastric emptying rates after ingestion. The halftime, t
1/2
, 
indicating when 50% of ingested meal is emptied, ranges 
from 10 to 60 min for liquid meals [86], whereas t
1/2
 reported 
for solid foods ranges from 50 min (bread and noodles) to 115 
min (beef liver) [87–90]. Gastric emptying rate is influenced 
by other meal components [87], meal volume [91], 
caloric content [92], the ratio between liquid and solid in the 
meal [93], and the type of dietary fibers [94]. Furthermore, 
for solid food, chewing efficiency and the degree of 
disintegration of the swallowed bolus affect gastric 
emptying rate [90] and, consequently, the kinetics of nutrient 
absorption [95].
Conflicting data are reported in the literature 
regarding the effect of aging on gastric emptying rate. Some 
studies reported no significant effect [96, 97] whereas others 
reported only a trend toward prolonged gastric emptying 
of solids and slightly faster emptying of liquids [98, 99], 
the increase in liquid outflow from the stomach being 
explained by a reduced compliance of the antrum [99]. 
Finally, some studies observed a significant increase of 
30–40% in solid and liquid gastric emptying time in the 
elderly [100–102]. Consequently, no clear conclusions 
on this research area can be made, mainly because of the 
variability of measurements and strongly differing health 
states in the elderly population. In this context, a study 
divided this population in frail and non-frail elderly and 
showed that, compared to young adults, gastric emptying 
time significantly increased in frail elderly, whereas it was 
unchanged in non-frail elderly [99].
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Small bowel
Small bowel transit time in young adults ranges from 
2 to 6 h [97, 103]. The effect of aging on small intestinal 
motility is not very well documented in the literature. 
Although the propagation velocity of phase 3 of the 
migrating motor complex is slower in the elderly, the patterns 
of motility and the transit rate appear to be maintained in the 
small intestine during aging [97, 104–106].
Colon
Few studies specifically investigated the effect of 
aging on colonic transit time. Metcalf et al. [107] reported 
no significant effect of aging on the transit time in the 
different segments of the colon whereas Madsen and Graff 
[97] evidenced a significant increase of colonic transit time 
in older subjects (+70%). Of note, environmental factors, 
such as physical inactivity [108], can largely increase 
colonic transit time. These confounding factors make it 
difficult to conclude on the specific role of aging. Of note, 
the prevalence of constipation increases with age. 30–40% 
of community-dwelling older adults and over 50% of 
nursing home residents experience chronic constipation. 
However, constipation does not seem a physiological 
consequence of normal ageing and the underlying reasons 
for constipation in advanced age include insufficient fluid 
and dietary fiber intake, reduced physical activity, age 
associated diseases, and chronic medications [109].
In conclusion, the effect of aging segmental transit 
time in the gut has not been sufficiently investigated and 
conflicting results do not allow to make clear conclusions. 
Transit time could be prolonged in the stomach and the 
colon. This effect seems weak for the general population, 
but could be significantly more pronounced in elderly 
with masticatory deficiency, reduced physical activity, 
and frailty syndrome. The diversity of experimental 
approaches measuring regional transit time also explains 
result inconsistency. These methods include mainly 
scintigraphy, radio-opaque markers, ultrasonography, 
breath tests, and paracetamol test, the last three methods 
being specific for the stomach. In addition, the use of 
wireless motility capsule is developing. This technology 
can provide information on intraluminal pH and pressure, 
is cheap and ambulatory, and the data correlates well with 
scintigraphy [110]. Wireless motility capsule is thus a very 
interesting tool to increase knowledge on the evolution of 
the regional gut transit during aging.
Motility and its regulation
Although gut motility seems impaired in older 
subjects, it is not clear whether this impairment is 
directly linked to a decreased ability of smooth muscles 
to contract and relax or to alterations in the regulation of 
these movements by the enteric nerves or specialized cells 
such as the interstitial cells of Cajal. At the level of the 
smooth muscle itself, impairment in signal transduction 
of the phosphorylation of the light chain of myosin [111] 
as well as perturbation of calcium signaling [112] have 
been evidenced in the colon. Few studies have specifically 
addressed the effect of advanced age on enteric nervous 
system. Hanani et al. [113] observed a significant change 
in the morphology of the myenteric plexus of the human 
colon (increase in cavities) as a consequence of aging, 
but this observation was mainly driven by the increase in 
the cavities observed between 0–25 y, variations between 
50–90 y being much less significant. However, supporting 
the hypothesis of an increase in abnormal myenteric 
ganglia in elderly, Bernard et al. [114] evidenced a 
neuronal loss in the myenteric plexus, this loss being 
specific to the cholinergic subpopulation, whereas 
nitrinergic neurons were spared. In animal models, the 
decrease in the number of neurons in advanced age is 
controversial [115]. However, signs of neurodegeneration 
have been clearly observed, as indicated by swollen 
and dystrophic nerve fibers, lipofuscin accumulation, 
and protein alpha-synuclein aggregates accumulation 
[115, 116]. The accumulation of aggregates could be 
linked to deficiency in macrophage and proteolytic 
activity [116, 117]. Studies in human elderly failed to show 
significant changes in neuron number in the submucosal 
plexus [114, 118]. However, a study in rodents showed 
that a decline in the number of neurons could be very 
progressive and specific to the distal colon plexus [119]. 
For networks of interstitial cells of Cajal, which contribute 
to segmenting and peristaltic contractile activity, a decline 
in density and volume has been observed in the colon of 
elderly subjects [120, 121].
In conclusion, more than a reduction in number, 
the degeneration of neurons and glia may partly explain 
modifications in GIT motility during aging.
Food digestion
Food digestion is ensured by different enzymes 
secreted in the first part of the digestive tract (from mouth 
to duodenum) and by microbial digestion in the hindgut.
Digestion by endogenous enzymes
Saliva
Saliva contains alpha-amylase involved in 
polysaccharide digestion. Conflicting data has been reported 
regarding the effect of advanced age on salivary flow. The 
latest study in this area showed a significant decline (−50%) 
of saliva in elderly [122] independently of medication. In 
agreement with this finding, various morphometric and 
histopathological changes have been described in old mice 
[123]. However, despite the decrease in secreted saliva 
volume, a greater daily alpha-amylase output has been 
observed in advanced age [124]. Some lipolytic activity has 
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been detected in oral cavity; however it is weak and only 
involved in oro-sensory fat detection [125, 126].
Stomach
In healthy elderly, gastric acid secretion was 
reported to be either unaffected [127–130] or increased 
[131]. However, Helicobacter pylori infection and 
atrophic gastritis are both associated with a decline in 
gastric acid secretion and their prevalence increases 
with age. Regarding pepsin, both basal and stimulated 
secretions decline after 70 y (divided by four between 
70 y and 90 y) and this decline is independent of atrophic 
gastritis and H. pylori infection [128].
Pancreas
Studies in animal models showed a decrease in 
pancreatic secretions in advanced age [132–134]. In 
particular old animals are unable to adapt their pancreatic 
exocrine secretion to changes in dietary intake. Three 
studies conducted in humans, in which pancreatic exocrine 
secretions were recorded by duodenal collection, showed 
that, compared to young controls, subjects above 65–70 
y had significantly reduced bicarbonate and enzyme 
(lipase, chymotrypsin, amylase) secretions, due to both a 
decrease in secreted volume and enzyme concentrations 
[135–137]. In agreement with these findings, magnetic 
resonance imaging evidenced an increase in pancreatic 
atrophy, lobulation, and fatty degeneration during aging 
[138]. Using fecal elastase-1 as a marker of pancreatic 
exocrine dysfunction, a large population-based study 
(50–75 y) reported a clear increase in exocrine pancreatic 
insufficiency with aging [139]. The same observation was 
made in a population of persons older than 80 y having 
no factors known that increase the prevalence of pancreatic 
deficiency, in particular gastrointestinal disorder, surgery, or 
diabetes mellitus [140]. Using strict selection criteria that 
ensured a very good health status of the included subjects, 
Gullo et al. [141] observed no significant impairment of 
the pancreatic function in very old subjects (> 91 y). In 
conclusion, the pancreatic exocrine secretion does decline 
in advanced age. This decline may, however, not be 
sufficient to cause maldigestion. Despite advanced age, the 
number and mass of β-cells are relatively well preserved 
in the endocrine pancreas of nondiabetic individuals, 
compared with the exocrine pancreas [142]. Age-related 
impairment of pancreatic beta-cell function has been 
reviewed by De Tata [143] and will not be described 
here. Of note, however, ageing is clearly associated with 
a decline in insulin action (insulin resistance), resulting in 
higher fasting and postprandial glucose concentration [144].
Bile
Biliary secretion does not contain enzymes and, 
thus, is not directly involved in digestion. Nevertheless, 
bile contains bicarbonate, which helps in the 
neutralization of chyme pH, and biliary salts, which are 
involved in fat absorption. Both fasting and maximally 
contracted gallbladder volumes are not affected in 
old age [145, 146]. Similarly, the secretion of total 
bile acid seems not to be affected by aging [145, 147]. 
However, bile acid reabsorption could be impaired in 
elderly [145].
Microbial digestion
A reduced biodiversity and compromised stability 
of the intestinal microbiota is often observed in elderly 
when compared to younger subjects [148]. The effect 
of aging on Firmicutes and Bacteroidetes, the two 
dominant divisions of the gut microbiota, and their ratio is 
controversial [149]. At a lower phylogenetic level of the 
microbiota, facultative anaerobes, including opportunistic 
proinflammatory bacteria, increase in advanced age, 
whereas health-promoting bacteria, such as Bifidobacteria, 
seem unaffected [149]. The composition of the microbiota 
of elderly significantly correlates with measures of frailty, 
co-morbidity, nutritional status, and markers of 
inflammation [150]. The effect of age-related microbiota 
changes on the digestive function of the colon is, however, 
less documented. Functional metagenomics showed 
that the age-related trajectory of the gut-microbiome is 
characterized by loss of genes for short-chain fatty acid 
production and an overall decrease in the saccharolytic 
potential, while the proteolytic potential seems to increase 
[151]. In line with these observations, a lower colonic 
fermentation has been observed in elderly women, 
compared to young women, after ingestion of a test 
meal [106].
The gut wall
Mucosal turnover
The epithelium of the GIT undergoes constant and 
rapid renewal (every 2 to 6 days according to the gut 
segment and diet). After removal of the confounding 
effect of diet, animal models showed that the architecture 
of the epithelium (such as villus height and crypt depth) is 
globally unaffected in advanced age [152, 153]. Similarly, 
no morphological changes of the duodenum were observed 
in elderly subjects [154]. A hyperproliferative state 
balancing an increased rate in enterocyte apoptosis was 
proposed to account for this lack of morphological change 
[155]. The total surface area available for absorption in 
the small intestine is therefore not deeply affected by 
aging. The increase in cell proliferation is accompanied 
by a rise in expression and activation of several tyrosine 
kinases, including the epithelial growth factor receptor 
(EGFR). The increase in EGFR activation with age could 
be linked to a decrease in the EGFR-related peptide, a 
negative regulator of EGFR [156]. In contrast to the data 
reported for the human duodenum, studies in the colon 
of rodents showed an increased mucosal cell proliferation 
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accompanied by decreased apoptosis. This decrease could 
be explained by decreases in ‘cell cycle and apoptosis 
regulatory protein-1’ (CARP-1) that participates in EGFR-
dependent signaling [157].
Permeability
On the basis of the lactulose/mannitol test, which 
delivers a permeability index, the tightness of the small 
intestine barrier appears to remain intact with advancing 
age [158, 159]. The situation could be different at the 
level of the colon as a study in non-human primates 
found a higher intestinal permeability in aged animals, 
in connection with a remodeling of tight junction 
proteins [160].
Carrier function
Using an ex-vivo approach in an aging rodent 
model, Woudstra et al. [161] did not observe age-related 
quantitative changes in lipid uptake (per unit of mucosal 
surface area), ileal lipid-binding protein (ILBP), and the 
cytosolic fatty acid binding protein (FABP). However, 
in a mice model, a significant increase in cholesterol 
absorption was observed, in line with an increased biliary 
cholesterol output, and an up-regulation of the expression 
of the influx transporter NPC1L1 in the different segments 
of the small intestine [162]. One study reported a complete 
profiling of the transporters involved in fatty acid (FATP4, 
FABPpm, FAT/CD36) and cholesterol absorption 
(NPC1L1, ABCG5/ABCG8, ABCA1) in humans aged 
37 y to 83 y [163]. However, the sample size of the study 
was limited (n = 11) and the authors did not find any 
decrease in lipid transport proteins with aging.
In contrast to proteins, the uptake of sugars, 
expressed on the basis of mucosal surface area, appears 
to be influenced by age as fructose uptake was reported 
to increase in advanced age whereas glucose uptake 
declined [164, 165]. These modifications were, however, 
not explained by variations in the transporters GLUT2, 
GLUT5, or SGLT1. The effect of aging on intestinal amino 
acid and peptide transporters has not been investigated in 
humans. However, a study in mice suggested that amino 
acid uptake by intestinal wall is not affected by aging [166].
Calcium absorption relies on both passive and 
active uptake processes through the enterocytes. The 
main proteins involved in active calcium absorption 
are the calcium-binding protein calbindin-D
9k
, the 
luminal channel transient receptor potential vanilloid 6 
(TRPV6), and the plasma membrane Ca2+-ATPase 
(PMCA1b). The expression of these proteins declines 
in advanced age [167, 168]. Furthermore, tight 
junction proteins (claudin-2 and claudin-12) could 
also facilitate paracellular calcium transport [169] 
but the effect of aging on this pathway is not known. 
Many proteins involved in active- or facilitated calcium 
absorption are upregulated by 1α,25-dihydroxyvitamin 
D
3
 (1,25(OH)
2
D
3
), whose ability to stimulate calcium 
influx markedly decreases with age. Possible causes 
involved in the modification of the 1,25(OH)
2
D
3
 response 
with age have been reviewed by Gonzales-Pardo and 
Russo de Boland [170].
Heme and non-heme iron are absorbed in the small 
intestine by separate mechanisms. The uptake of inorganic 
iron in the brush-border of duodenal enterocytes relies on 
the divalent metal transporter DMT1, whereas heme-iron 
uptake is mediated by a heme transporter. Iron is then 
stored in the cytoplasm as ferritin and the basolateral 
export of iron (Fe2+) is mediated by ferroportin [171]. The 
effect of aging on the expression of the proteins involved 
in iron absorption is not documented.
Intestinal barrier and immune system
The impact of aging on the intestinal barrier and 
immune system has been recently reviewed by Man 
et al. [172]. The first actors in the barrier function of the 
intestine are the anti-microbial peptides (AMPs) that are 
secreted by epithelial cells and the mucus layer, which 
covers the epithelium. Whether aging impacts on AMPs 
is not known. Apart from H. pylori positive subjects, the 
thickness of the mucus layer is not altered in the elderly 
[173]. The impact of aging on the chemical composition 
and structure of the mucus layer is not documented. 
However, modifications of the mucus could explain the 
reduced ability of bifidobacteria to bind to the mucosa of 
elderly [174].
Aging is associated with a progressive decline 
of the mucosal immune response in the intestine, a 
process coined with the term “immunesenessence”. 
The production of antigen-specific immunoglobulin A, 
which is a key function of the mucosal immune response, 
decreases in elderly persons [175]. The ability of the 
aging immune system to generate tolerance to harmless 
antigens is also reduced [176]. Whereas the age-related 
changes in the systemic immune response are well 
documented, much less is known about the mechanisms 
underlying the decline of the immune function in the 
intestine. In that context, a dramatic decline in the density 
of mature M cells was observed in the Peyer’s patches 
of aged mice [177], reducing the ability to transcytose 
particulate luminal antigens across the epithelium. 
Finally, the density of mononuclear phagocytes in Peyer’s 
patches is not affected by aging [177] but the number and 
functionality of dendritic cells, which present antigens to 
immunocompetent B and T cells, are decreased what may 
explain the lack of oral tolerance in advanced age [178].
Endocrine function
Gastrin is a peptide hormone mainly secreted by 
the G cells of the stomach antrum, which stimulates 
postprandial acid secretion. Except in subjects suffering 
from H. pylori infection, plasma gastrin concentrations do 
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not seem to be affected by aging [127]. An increase in 
gastrin receptor gene expression in the stomach has been 
reported in rodents [179] but similar studies in humans 
are not available. Secretin, which is secreted by S cells in 
the first part of the small intestine, stimulates bicarbonate 
pancreatic secretion, and inhibits gastric acid secretion. 
Whether aging affects this secretion is not known.
CCK is mainly released from I cells in the 
duodenum and ileum in response to the inflow of digesta 
into the small intestine. CCK stimulates the release of 
digestive enzymes from the pancreas and gallbladder 
contraction. Furthermore, this hormone increases intestinal 
motility, inhibits gastric emptying, and is considered as 
a strong anorexigenic gastrointestinal hormone. Using 
standard test meals, a lower CCK postprandial response 
has often been reported in elderly compared to young 
subjects [99, 180–182].
Ghrelin, an orexigenic hormone, is mainly 
produced in the stomach, but also in the proximal small 
intestine. In contrast to other gastrointestinal peptides, 
the synthesis of ghrelin increases with fasting. The effect 
of aging on total plasma ghrelin is unclear. Some studies 
reported a decreased basal ghrelin production in elderly 
[183, 184] but no differences were observed in other 
studies [99, 181, 185]. Also, the postprandial decrease in 
plasma ghrelin was either blunted [184, 185] or unaffected 
[99, 181]. Acyl-ghrelin is the active form of ghrelin. 
A recent study showed that, on the basis of a 24-h post-
meal sampling, plasma acyl-ghrelin concentrations are 
lower in older adults than in young men [186].
PYY is primarily released from the ileum and the 
large intestine. In addition to inhibiting food intake, 
PYY also delays gastric emptying, inhibits intestinal 
motility, and decreases pancreatic secretions. Plasma 
PYY concentrations do not appear to be affected in the 
elderly [180]. In agreement with this finding, the density 
of the endocrine cells that produce PYY is not affected by 
aging [187].
The incretin hormones glucose-dependent 
insulinotropic polypeptide (GIP) and glucagon-like 
peptide 1 (GLP1) are produced at the beginning (K cells 
of the duodenum) and end (L cells of the ileum) of the 
small intestine, respectively, in response to the presence 
of nutrients within the digestive lumen. The main roles 
of GLP1 are to increase insulin secretion, decrease 
glucagon secretion from the pancreas, inhibit gastric acid 
secretion and gastric emptying, and decrease appetite and 
food intake. As GLP1, GIP promotes insulin secretion 
by the pancreas. Although a majority of studies showed 
no significant alteration in postprandial GLP1 and GIP 
response in non-diabetic elderly [99, 180, 188], one study 
reported an increased postprandial secretion of GIP and 
GLP1 in postmenopausal women [189]. Glucagon-like 
peptide 2 (GLP2) is co-secreted with GLP1 by the L-cells 
in response to the ingestion of nutrients. GLP2 stimulates 
intestinal growth and mucosa repair, improves nutrient 
absorption, and slows down gastric motility. The effect of 
aging on GLP2 secretion is not known.
In conclusion, the main changes in the release of 
gastrointestinal peptides in advanced aged are an alteration 
of the postprandial response of CCK and ghrelin.
Consequences of the aging GIT on 
nutrient bioavailability
Macronutrients
Although the secretion of pepsin and pancreatic 
enzymes declines with advancing age (see Section 2.1.3), 
proteolytic activity in the small intestine still appears to 
be sufficient to ensure a proper digestion of proteins in the 
elderly. However, studies in aged rodents showed a lack of 
adaptability of protein digestion to nutritional stress, such 
as food restriction [190] or the presence of antinutritional 
factors in the diet [191]. Because of their technical 
difficulty, measurements of protein digestibility in the 
small intestine of humans are scarce and none has been 
performed in the elderly. It is, thus, not known if brush-
border peptidases, peptide transporters, and amino acid 
transporters are affected by aging. Nonetheless, scientific 
evidence suggests that these proteins are not limiting the 
absorption of amino acids in the small intestine of the 
elderly. However, peripheral availability of amino acids 
could be strongly affected by an increased metabolic use 
of dietary amino acids in the GIT and the liver [192, 193].
As for protein digestion, it is not known if starch and 
lipid digestion in the small intestine are adversely affected 
by the small decline in amylase and lipase secretion 
observed in the elderly. Indeed, no data is available in the 
literature on the digestibility of starch or lipid in the small 
intestine of elderly. More specifically, it is not known 
whether the bioavailability of essential fatty acids (EFAs), 
in particular linoleic acid (LA, 18:2 n-6) and α-linolenic 
acid (ALA, 18:3 n-3) is impaired with advancing age, 
although one study reported the same bioavailability of 
ALA in young subjects and 45–69 y subjects [194].
Vitamins and minerals
Vitamin B12 deficiency concerns about 15% of the 
elderly population [195]. This deficiency can be due to 
either malabsorption of food-bound cobalamin or to an 
insufficient dietary intake, the latter mostly resulting from 
a decrease intake in animal products. Food-bound vitamin 
B12 is released by pepsin in the acidic environment in the 
stomach where it binds to a gastric protein (the R binder). 
Subsequently, vitamin B12 is released by pancreatic 
enzymes in the small intestine where it binds with intrinsic 
factor. The cobalamin-intrinsic factor complex then binds to 
the ileal endocytic cubam receptor formed of two proteins, 
cubulin and amnionless. The cubam receptor mediates 
endocytosis of the intrinsic factor-cobalamin complex, 
which is then degraded in lysosomes to release cobalamin 
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into plasma in complex with transcobalamin II. Cobalamin 
malabsorption in the elderly could therefore stem from a 
decrease in pepsin or acid secretion, a lack of intrinsic factor, 
or other defects in the cobalamin uptake system [196].
The digestion and absorption of the fat-soluble 
vitamins A, D, and E basically follow the same path 
as lipids. As such, membrane proteins are involved in 
the absorption of these vitamins [197–199]. The effect 
of aging on the expression of these carriers and on the 
bioavailability of fat-soluble vitamins is not known.
Intestinal absorption of calcium decreases with 
age [200, 201]. Calcium absorption has both an active 
(1,25(OH)
2
D
3
-dependent) and passive component (see 
Section 2.1.4.1). Elderly women have an impaired 
intestinal response to 1,25(OH)
2
D
3
 that may contribute to 
their negative calcium balance and bone loss [202]. The 
dietary source of calcium (milk, calcium carbonate, or 
fortified orange juice) does not seem to affect its relative 
bioavailability in elderly [203]. The effect of aging on the 
bioavailability of the other minerals is not documented. 
However, for some of these minerals, such as iron, the 
luminal pH is an important factor for their absorption. 
As such, the hypochlorydria observed in elderly subjects 
suffering from atrophic gastritis could decrease the 
bioavailability of these minerals [204].
Water
The GIT is the location of very intense water 
fluxes. On a daily basis we consume about 2 L of water 
and about 7 L of water are secreted into the GIT via the 
different digestive secretions. The largest part of this water 
is reabsorbed in the small intestine (about 8 L) and, to 
a lesser extent, by the colon. The high permeability of 
the small intestine ensures a rapid osmotic rebalancing 
of the digestive content during the absorption of ions 
and nutrients. Water can cross the GIT epithelium via 
the paracellular or transcellular route. The relative 
significance of both routes in the different digestive organs 
has been reviewed elsewhere [205]. The transcellular 
route involves three different mechanisms, namely 
passive diffusion, cotransport with ions and nutrients 
(for example through SGLT1 transporter), and the water 
channels named aquaporins [206]. Currently it is not 
known if potential modifications in tight junction proteins, 
membrane transporters, or aquaporins can impaired water 
bioavailability in the elderly.
CONSEQUENCES OF MALNUTRITION 
ON FUNCTIONAL DECLINE OF ORGAN 
SYSTEMS
Malnutrition and aging are associated with 
progressive deterioration of health and physical 
performance in older adults. This deterioration leads to 
decreased functional abilities, dependency in activities 
of daily living, poor quality of life, and further decline in 
physical activities.
As can be concluded from Part 2 of this review, age-
related changes in the gut may enhance the occurrence and 
severity of malnutrition by several paths that differ by the 
specific GIT organ system. In this part, the consequences 
of malnutrition on the most sensible organ systems of 
the elderly will be addressed. The impact of malnutrition 
on the severity of diseases, health complications and 
mortality is also presented.
Nervous system
Altered cognitive functions and neurodegenerative 
diseases may be the cause or the result of malnutrition. 
Likewise depression may either be the cause or the result of 
decreased dietary intake as specific deficiencies in nutrients 
may accelerate depressive symptoms [207]. Indeed, 
depressive symptoms are more prevalent in individuals 
with impaired nutritional status manifested in diets of poor 
quality, unintentional weight loss, and a decreased intake 
of specific nutrients [208, 209]. In particular, deficiencies 
in vitamin B9 (folate) [210], vitamin B12 [211], vitamin 
B6 [212], and polyunsaturated fatty acids (PUFAs) are 
associated with depressive symptoms [213] and declining 
cognitive functions [214] in older age.
The brain is a site of high metabolic activity and 
is especially prone to oxidative stress and damage to 
neural tissue [214]. A prevailing theory is that oxidative 
damage and neural inflammation are the underlying 
biological mechanisms of neurodegenerative disorders like 
Alzheimer’s disease and Parkinson’s disease [215, 216].
Oxidative stress, which is defined as an excess 
of reactive oxygen species (ROS), is also the main 
mechanism inducing damage to the retina in age-related 
macular degeneration (AMD). Oxygen exacerbates 
physiological and molecular damage to the eye during 
aging via free-radical chain reactions [217]. The relation 
of ROS to diet is two-edged as the metabolism of 
macronutrients enhances the production of ROS and some 
nutrients can inhibit this process.
ROS appears to play a major role also in the 
degeneration of hearing during aging [218, 219]. Age-related 
hearing loss, or presbycusis, is a complex degenerative 
disease and one of the most prevalent chronic conditions in 
elderly, affecting tens of millions worldwide [220]. As for 
other neurodegenerative diseases, hearing loss is inversely 
associated with the intake of antioxidant vitamins, although 
most studies were performed in animal models. In particular, 
rats and dogs fed a diet rich in antioxidant vitamins showed 
less degeneration of the spiral ganglional cells and the stria 
vascularis compared to animals fed a control diet [221, 222].
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Antioxidant vitamins and phytochemicals
The nutrients involved in the counteraction of 
oxidative damage include elements such as Mn, Cu, and 
Se, which are part or co-factors of antioxidant enzymes, 
as well as the antioxidants vitamin E and vitamin C. 
Carotenoids and flavonoids may also be indirectly 
involved in cellular mechanisms protecting against 
oxidative stress. The antioxidant nutrients may play more 
important roles in the aging brain than in other organs 
of the body because of the reduction in the number of 
antioxidant enzymes that provide neuronal protection 
[223]. A reduced intake of antioxidant nutrients, which is 
characteristic of diets of poor quality and of malnutrition, 
may thus adversely affect cognitive function.
There is a weak evidence to support protection against 
dementia by dietary intake of nutrients such as vitamin C 
and β-carotene. The single dietary antioxidant with a 
prominent evidence for a protective effect on cognition 
is vitamin E. Indeed, prospective epidemiological studies 
on dietary vitamin E consistently showed statistically 
significant inverse associations with incident dementia, 
Alzheimer’s disease, and cognitive decline [223, 224].
Molecules with an effect on AMD susceptibility 
include carotenoids (lutein, zeaxanthin, β-carotene), 
which show the most convincing results, although still 
inconsistent. In addition, weak protective effects of 
vitamins (A, B, C, D, E), minerals, dietary fats, and dietary 
carbohydrates were also suggested [225].
As mentioned above, studies on the relationships 
between lutein, zeaxanthin, β-carotene and AMD are 
conflicting. A case-control study focusing on the effect of 
carotenoids on AMD was performed by the Eye Disease 
Case-Control Study Group [226]. This study recruited 
421 patients with neovascular AMD and 615 controls. 
High serum levels of carotenoids were associated with 
a reduced risk of neovascular AMD. In particular, the 
odds ratios for AMD in subjects with sufficient intake 
of lutein, zeaxanthin, β-carotene, alpha-carotene, and 
cryptoxanthin ranged from 0.3 to 0.5. However, overall 
consistency across studies was lacking. Some studies 
failed to identify a correlation between AMD and the 
intake of vegetables, antioxidant vitamins, or carotenoids. 
Other studies reported a direct inverse association 
between the dietary intake of lutein and zeaxanthin and 
the occurrence of AMD [227, 228]. Notably, a large study 
of 4,519 participants, performed by the Age-Related Eye 
Disease Study Research (AREDS) Group, reported a low 
likelihood of AMD in people with a high dietary intake 
of lutein and zeaxanthin [226]. Carotenoids intake is 
related to the intake of fruits and vegetable. In that regard, 
the National Health and Nutrition Examination Survey 
showed an inverse association between the frequency of 
intake of fruits and vegetables rich in carotenoids and the 
prevalence of AMD [229].
A review by Zampatti et al. [225] that includes 
several studies reported a weak or non-existent association 
between serum vitamin E levels, the consumption of 
vitamin E supplements, and the risk of AMD. The AREDS 
Group demonstrated an inverse association between the 
intake of vitamin C and E and neovascular AMD [226]. 
However, these results were not repeated in other studies. 
In particular, no significant association between vitamin C 
intake and AMD was observed in the Eye Disease Case-
Control Study Group or in the POLA study [226, 230]. The 
National Health and Nutrition Examination Survey study 
showed an inverse association between the plasma levels 
of vitamin D and early AMD, whereas an association was 
no longer reported for advanced AMD [231]. Of note, 
the anti-inflammatory properties of vitamin D are of 
additional interest in the prevention of AMD in light of 
the inflammatory component of AMD [232].
AMD weakly and inversely associates with the 
intake of minerals such as zinc, copper, and selenium. 
These minerals are at risk for deficiency in the general 
population with increased incidence among the elderly. 
The food sources for these minerals are specific and 
costly, including red meat and poultry (as sources of zinc) 
as well as bread, grain, meat, fish, and eggs (as sources 
of selenium). The intake of meat, poultry, and fish is, 
thus, often compromised in the elderly, leading to dietary 
deficiencies and malnutrition.
Finally, the Korea National Health and Nutrition 
Examination Survey conducted a study in South Korea 
demonstrating that dietary intake of vitamin C was 
positively associated with hearing quality in an elderly 
cohort. However, due to high rates (> 50%) of insufficient 
intake of vitamins in the control group, a proper diet in 
itself may have prevented hearing decline [218].
B vitamins
Among the B vitamins, vitamin B9 and B12 
have received the greatest attention for brain health in 
the scientific literature. These vitamins are co-factor 
nutrients that modulate neurocognitive development 
and neurodegeneration. Data from epidemiological 
studies and randomized clinical trials on the relationship 
between vitamins B9 and B12 and cognitive deterioration 
is conflicting [233] and depends on the study designs 
and the various methods used for evaluating cognitive 
function. In recent years, vitamins B9 and B12 have 
received a lot of attention as risk factors for dementia. This 
interest was largely based on their function as co-factors 
in the metabolism of homocysteine. Homocysteine has 
been associated with the risk of developing Alzheimer’s 
disease in some [234, 235] but not all studies [236]. 
The role of homocysteine is thus still debated, even though 
its mechanism of action in this pathology is not known. 
Of note, homocysteine deficiency is neurotoxic in mouse 
models of Alzheimer’s disease [237].
Elderly at nutritional risk are characterized by 
low levels of vitamin B12. Even among elderly with 
appropriate intake, blood levels of vitamin B12 are 
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frequently low [233, 238, 239]. The intake of B vitamins, 
particularly vitamin B12, folic acid, and vitamin B6 are 
related to homocysteine levels. As AMD is also associated 
with elevated levels of plasma homocysteine, B vitamins 
are of particular interest in the prevention of AMD. 
Indeed, plasma vitamin B12 concentrations were lower in 
patients with exudative AMD compared to controls and 
patients with AMD [240].
Among women participating in the Health, Aging, 
and Body Composition (Health ABC) Study [241, 242], a 
poor vitamin B12 and folate status was associated with 
age-related auditory dysfunctions. In particular, women 
with an impaired hearing had lower serum vitamin B12 
levels (38%) and lower red cell folate levels (31%) than 
women with normal hearing. These results were confirmed 
in women taking supplements of B12 or folic acid.
Polyunsaturated fatty acids
The EFAs LA and ALA, and their longer and 
more unsaturated derivatives, arachidonic acid (ARA, 
20:4 n-6), eicosapentaenoic acid (EPA, 20:5 n-3), and 
docosahexaenoic acid (DHA, 22:6 n-3), play key roles in 
both cell structure and function, and are thus indispensable 
for brain development. ARA and DHA are found in large 
concentrations in brain lipids, and nearly 6% of the dry 
weight of the brain is built of n-3 PUFAs [243]. PUFAs are 
incorporated into phospholipids and are key components 
of the brain neuronal and glial cell membranes. PUFAs 
provide fluidity and the proper environment for an active 
functioning of integral proteins. Moreover, PUFAs 
esterified in phospholipids have a role in cellular function 
because they are a reservoir of signaling messengers 
for neurotransmitters and growth factors. PUFAs 
regulate both eicosanoid and proinflammatory cytokine 
production, which play a key role in depression and 
neurodegenerative diseases linked to aging. Overall, n-3 
PUFAs are considered anti-inflammatory while n-6 PUFAs 
pro-inflammatory. In addition, PUFAs are involved in 
the regulation of gene expression. n-3 and n-6 PUFAs 
compete for enzymes involved in both biosynthesis of 
long-chain PUFAs (LC-PUFAs) from the corresponding 
EFA and conversion of specific LC-PUFAs to eicosanoids. 
Considering that LA conversion is more efficient than ALA 
conversion, an excess of the n-6 precursor LA promotes 
the formation of ARA and related pro-inflammatory 
eicosanoids [244].
LC-PUFAs are not only synthesized from EFAs, 
but can also be introduced with food. DHA and EPA 
are mainly found in fish oils and fatty fishes whereas 
ALA is commonly found in vegetable oils. The dietary 
intake of n-6 PUFAs (both as LA and LC-PUFAs) largely 
exceeds the intake of n-3 PUFAs. PUFAs are believed 
to have occurred in early diets at a ratio n-3:n-6 of 1:1. 
Nowadays, this ratio ranges between 10:1 and 30:1 and 
this dietary imbalance may increase susceptibility to 
neuronal damage.
Experimental studies have shown that n-3 PUFAs 
are involved in many neurobiological processes, indicating 
that they may prevent age-related brain damage [245].
Muscoskeletal system
Age-related changes in body composition 
and malnutrition
In healthy adults, muscles constitute over half of 
total body protein. The muscle mass, however, decreases 
with age due to greater rates of protein breakdown than 
synthesis. Aging is also accompanied by an infiltration 
of adipose cells in muscle tissues, which is associated 
with a decreased muscle strength and insulin resistance. 
Changes in ‘muscle quality’, expressed as the amount of 
force produced per unit of muscle mass, explain much 
of the strength loss during aging. These age-related 
neuromuscular modifications include reductions in the 
number, size, and contractility of muscle fibers, as well 
as skeletal muscle fat infiltration. Neuromuscular changes 
along with increased body fat, systemic low-level 
inflammation, and oxidative stress contribute to further 
deteriorations of the muscoskeletal system eventually 
leading to sarcopenia [246], osteoporosis, weight loss, 
and frailty.
Sarcopenia was defined by the European Working 
Group on Sarcopenia in Older Persons (EWGSOP) as a 
loss of muscle mass in combination with a loss of muscle 
strength or physical performance [247]. Sarcopenia is 
measured with a range of indicators, including relative 
skeletal muscle mass, total muscle mass, handgrip, and 
physical performance, and affects up to one-quarter of 
older adults [247]. Sarcopenia is associated with a reduced 
ability to complete everyday tasks and an increased risk of 
falls, this phenomena resulting in a loss of independence 
in elderly [248].
The decline of bone mineral density (BMD) with 
increasing age can lead to osteopenia and, in extreme 
cases, to osteoporosis. The latter is a significant health 
problem that contributes to disability and premature 
mortality among older women and men. Although genetic 
factors influence peak bone mass, diet is clearly one of 
the modifiable risk factors for osteoporosis [249]. Elderly 
are generally advised to strengthen their skeletal health 
by following a nutrient-dense diet that is also diverse and 
rich in fruits and vegetables. This diet should contain 
adequate amounts of proteins, vitamins (B, C, D, K), 
minerals (calcium, potassium, magnesium), and trace 
elements [250, 251].
Frailty is a geriatric syndrome characterized by a 
reduction of the physiological functional reserves and 
a decreased homeostatic capacity leading to greater 
vulnerability to adverse health outcomes including falls 
and fractures and increased risk of death. About 30% of 
community-dwelling persons older than 65 y experience 
one or more falls every year. About 5% of falls result 
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in a fracture and more than 90% of the hip fractures are 
attributable to falls. The consequences of hip fractures are 
severe: 50% of older persons have permanent functional 
disabilities, 15% to 25% require long-term nursing home 
care, and 10% to 20% die within one year [252]. The 
decrease in food intake associated with anorexia leads 
to a reduction in exercise capacity and to a decline in 
muscle mass and strength, and is therefore involved in the 
development of the frailty syndrome.
Sarcopenia, osteoporosis, and frailty are worsened by 
malnutrition and specific nutrients deficiencies, in particular 
protein, antioxidant vitamins, minerals, and fatty acids.
Proteins
The National Health and Nutrition Examination 
Survey (NHANES) revealed that approximately one-third 
of adults over 50 y of age fail to meet the Recommended 
Dietary Allowance (RDA) for protein, while approximately 
10% of older women fail to meet even the Estimated 
Average Requirement (EAR) (0.66 g protein/kg/day) 
[253]. A short fall of protein supplies relative to the needs 
can lead to loss of lean body mass, particularly muscle 
loss. The association between dietary protein intake, using 
a food frequency questionnaire (FFQ), and lean body 
mass, measured by dual energy x-ray absorptiometry 
(DEXA) over a 3 y period, was assessed in the Health 
ABC Study. After adjustment for potential confounders, 
participants in the highest quintile of protein intake lost 
approximately 40% less lean body mass than those in the 
lowest quintile of protein intake [254].
To maintain and regain lean body mass and 
muscle function, the PROT-AGE Study Group 
[255] recommended an average daily intake of at 
least 1.0–1.2 g protein per kilogram of body weight. 
Furthermore, increasing dietary protein should be 
integrated into an energy-controlled dietary plan for 
weight management. Dietary enrichment with leucine or 
a mixture of branched-chain amino acids (BCAA) may 
also help enhancing muscle mass and function [256]. 
β-hydroxy-β-methylbutyrate, a bioactive metabolite 
derived from leucine, showed some positive effects on 
muscle mass and function in some studies. The sample 
size of these studies was, however, small [247].
Several epidemiological studies reported that protein 
intake correlates positively with BMD and negatively 
with the rate of bone loss [255]. A prospective cohort 
study showed that elderly subjects with osteoporosis had 
a higher BMD when their daily protein intake exceeded 
0.8 g/kg body weight or comprised at least 24% of their 
total energy intake [257]. This finding was confirmed by a 
systematic review of this research field [258].
Antioxidants, vitamins, and phytochemicals
In Canadian adults aged 60–75 y, the odds for 
sarcopenia were greater in those who reported failing to 
meet the RDA for the antioxidants selenium and vitamins 
A, C, and E [259]. The Hertfordshire Cohort Study also 
observed a positive association between handgrip strength 
and the intake of β-carotene, selenium, and vitamin C 
[260]. The Women’s Health and Aging Study (WHAS) 
recruited nearly 700 community-dwelling women aged 
70–79 y and reported an inverse correlation between 
plasma carotenoid and vitamin E concentrations and the 
odds for low muscle strength and frailty [261]. Over 
3 years in this study, low baseline plasma concentrations 
of carotenoids were associated with a decline in walking 
speed [262]. Finally, low plasma concentrations of 
selenium were also associated with poor muscle strength 
in the CHIANTI Study [210].
Oxidative stress is a major mechanism in the loss of 
bone mass and strength as ROS influence the generation 
and survival of osteoclasts and osteocytes. In this 
context, dietary antioxidants such as vitamins (A, E, C) 
and phytochemicals such as carotenoids and flavonoids 
(quercetin) may play a protective role in bone health of 
elderly [250, 251].
Vitamin D plays an important role in bone and 
mineral metabolism, and its deficiency is closely 
associated with metabolic bone disease. Vitamin D is 
a secosteroid hormone produced by the skin following 
its exposure to ultraviolet B light. Vitamin D is also 
obtained from the diet, albeit in small amounts. Although 
controversy surrounds the definition of low vitamin D 
status, there is a general acceptance that the optimal 
circulating 25-hydroxyvitamin D
3
 (25(OH)D
3
) level 
should be at least 75 nmol/L. A threshold for optimal 
25(OH)D
3
 and hip BMD has been established from 
13,432 individuals in the Third National Health and 
Nutrition Examination Survey (NHANES III). NHANES 
III included both younger (20–49 y) and older (≥ 50 y) 
individuals with different ethnic background. This study 
shows that serum 25(OH)D
3
 levels were positively 
associated with BMD throughout the reference range of 
22.5–94 nmol/L in all subgroups [263].
Vitamin D deficiency is recognized as a worldwide 
epidemic, especially in the elderly, as a result of decreased 
sun exposure and, consequently, decreased intrinsic 
synthesis, lower dietary intake, and decreased vitamin D 
receptor (VDR) activity. More than 60% of postmenopausal 
women have deficient 25(OH)D
3
 serum levels, including 
populations in sunny countries such as in the Middle 
East, in Australia and in Spain. In elderly, vitamin D 
insufficiency and deficiency appear to be particularly 
prevalent in nursing home residents. Inadequate levels of 
vitamin D lead to a reduced intestinal calcium absorption, 
secondary hyperparathyroidism, impaired mineralization, 
and increased bone resorption [264]. The Institute of 
Medicine consequently recommends a daily dose of 
vitamin D supplement (800 IU) for elderly over 71 y [265].
Vitamin D affects fracture risk through its effects on 
bone metabolism and, consequently, on the risk of falling. 
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Daily supplementation of 800 IU vitamin D is needed to 
positively influence the rate of falls [266]. A meta- analysis 
published in 2005 showed that oral supplementation of 
700–800 IU vitamin D reduces the risk of hip and non-
vertebral fractures in ambulatory or institutionalized 
elderly [267]. Brincata et al. recommended in 2015 that 
a deficiency in vitamin D should be aggressively treated 
with higher pharmacological doses to achieve serum 
levels ≥ 75 nmol/L [264].
Nuclear VDRs in skeletal muscles bind 
1,25(OH)
2
D
3
, the active form of vitamin D, and promote 
protein synthesis. The apparent decrease in VDRs within 
the muscle during aging may explain part of the age-
related decline in protein synthesis [268]. Prospective 
studies suggested that vitamin D may be important for 
muscle function. The majority of studies in the research 
field of sarcopenia assesses 25(OH)D
3
, a precursor of 
1,25(OH)
2
D
3
. In the Longitudinal Aging Study Amsterdam 
(LASA) the odds of losing more than 3% of muscle mass 
over 3 y were close to two times greater in participants 
with low plasma levels of 25(OH)D
3
 at baseline 
(< 25 nmol/L) compared to participants with high levels 
(> 50 nmol/L) [269]. In the same study, the odds for a loss 
of grip strength greater than 40% over 3 y were around two 
times greater for participants with low serum 25(OH)D
3
 
levels at baseline than for those with high levels. 
Vitamin D may, therefore, play an important role in the 
maintenance of muscle function in elderly. In conclusion, 
plasma levels of 25(OH)D
3
 should be measured in elderly 
with muscle loss and values lower than 75 nmol/L should 
trigger dietary interventions and/or supplementation [269].
Calcium
Calcium is a key architectural component of bones 
and, thus, critical for the maintenance of bone health. 
Inadequate calcium absorption increases the concentration 
of parathyroid hormone leading to increased bone 
resorption. In the USA the RDA for calcium was recently 
raised to 1,200 mg/d for females aged 50–70 y [265]. 
For males, the recommendation remained at 1,000 mg/d 
whereas it was set at 1,200 mg/d for both genders over 
71 y. The calcium intake of postmenopausal women in 
Europe typically falls well below recommended values 
[270]. More than 50% of the older NHANES participants 
in 2005–2006 (a representative national survey of older 
adults in USA) failed to achieve the RDA for calcium, 
even with supplements. Furthermore, 1,384 members of 
the NHANES cohort aged 50–70 y and 71 + y, were tested 
for the association between total calcium intake and hip 
and spine BMD after adjusting for BMI. The total calcium 
intake ranged from a mean of 400 mg/d in the first quintile 
to 2,100 in the fifth quintile. However, little difference in 
hip or lumbar BMD was found in relation to total calcium 
consumption in women and men across the five quintiles. 
In particular, a dietary intake of calcium approaching or 
even meeting the current recommendations was not related 
to higher BMD of the hip or lumbar spine compared to the 
elderly subjects with lower intakes of calcium [271].
Polyunsaturated fatty acids
Several studies suggest a potential role of 
fatty acids on muscle, particularly n–3 LC-PUFAs, 
which predominately consist of EPA and DHA. The 
Hertfordshire Study, a large retrospective cohort study of 
nearly 3,000 community-dwelling older men and women 
aged 59–73 y, found a positive association between fatty 
fish consumption and grip strength [260]. The Reykjavik 
Study, a prospective cross-sectional study with a cohort 
of subjects aged 66–96 y at baseline, followed over 5 y 
the association between plasma PUFAs and measures of 
muscle size, intermuscular adipose tissue, and muscle 
strength. The results revealed inconsistent cross-sectional 
relations between the various plasma PUFAs measured 
and indicators of muscle health, including muscle size and 
strength, and intermuscular adipose tissue [272].
In pigs, maintaining dietary n-6:n-3 PUFA ratios of 
1:1–5:1 facilitates the absorption and utilization of fatty 
acids and free amino acids, and results in improved muscle 
and adipose composition [273].
The effects of n-3 PUFAs on BMD are unclear. 
Three studies found a positive relation between the 
consumption of n-3 PUFAs and BMD (total body, spine) 
[249, 274, 275]. In a cohort of 1,417 Chinese elderly living 
in the community fish intake was negatively associated 
with bone loss in hip and femoral neck, albeit only in men. 
A recent meta-analysis, however, concluded that the data 
currently available is insufficient to conclude on a positive 
effect of n-3 PUFAs on bone health [276].
Cardiovascular system
Cardiovascular disease
In general, the contribution of malnutrition to 
cardiac illness has been underestimated. Conventional 
medical theories relate cardiac disease and atherosclerosis 
to overnutrition, rather than undernutrition. Nonetheless 
it should be remembered that the heart is a muscle and 
thus becomes vulnerable to numerous micronutrient 
deficiencies such as vitamin A, vitamin C, vitamin E, 
thiamine, B vitamins, vitamin D, selenium, zinc, and 
copper [277].
These deficiencies compromise heart muscle 
function and may lead to heart failure. Additionally, the 
poor cardiac output emanating from prior cardiac injury 
(e.g. myocardial infarction) may lead to intestinal edema 
secondary to malabsorption and cardiac cachexia, an 
unintentional severe weight loss caused by heart disease 
[278]. Obviously these would all hasten complications and 
death. For example, in a study involving 171 patients with 
heart failure, cardiac cachexia was predictive of 18-month 
mortality independent of age, symptomatic classification of 
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heart diseases according to the New York Heart Association 
(NYHA), left ventricular ejection fraction, and exercise 
tolerance [279]. Another relevant factor is that cardiac 
patients tend to restrict their diet sometimes excessively 
as part of genuine or perceived recommendations for 
highly restrictive diets. Total adherence to such diets 
induces a vicious cycle characterized by malnutrition 
and deficiencies in the above mentioned nutrients, which 
ultimately aggravates cardiac failure and leads to clinical 
deterioration. Interestingly, Lennie et al. [280] proposed 
that factors such as decreased hunger sensation, diet 
restrictions, fatigue, shortness of breath, nausea, anxiety, 
and sadness may contribute to a decreased nutritional 
intake in patients with heart failure. Additional mechanisms 
for a poor micronutrient status in patients with heart failure 
include a decreased intestinal absorption as a consequence 
of gut edema, increased urinary losses due to drug therapy 
[212], and increased oxidative stress.
In conclusion, although malnutrition is secondary 
to cardiometabolic diseases, particularly heart failure, 
micronutrients deficiencies appear to significantly increase 
the morbidity and mortality associated with cardiovascular 
diseases (CVD).
Anemia
The prevalence of anemia increases with age and 
is a common condition in the elderly. Anemia affects the 
quality of life through cognitive and physical functions. 
It is a comorbid condition that affects other diseases 
(e.g. heart disease, cerebrovascular disorders) and is 
positively associated with the risk of death [281, 282]. 
Next to anemia mediated by inflammatory processes, 
iron deficiency anemia is the second most common cause 
of anemia in the elderly [283]. Iron deficiency anemia 
usually results from chronic gastrointestinal blood loss. 
In addition, malnourished elderly are at increased risk 
for iron deficiency due to inadequate dietary intake, 
absorption, and bioavailability of iron. This phenomena 
is worsened by the intake of anti-acid drugs [284]. 
As mentioned earlier in this review, both vitamin B12 
and folate deficiency are common among elderly, each 
occurring in at least 5% of anemic patients [285]. In the 
elderly, folate deficiency usually develops as a result of 
inadequate dietary intake [281]. In the case of vitamin 
B12, intestinal malabsorption of cobalamin results from 
changes in the functionality of the GIT (see Section 2.2.2), 
explaining over 50% of vitamin B12 deficiencies, the 
remaining being attributed to a poor dietary intake [233].
Immune system
The classical view of immune aging is of 
an immunodeficiency state that predisposes to 
progressive T-cell dysfunction with advancing age. 
Immunosenescence reflects the decreasing ability of the 
aging organism to react to the attacks of external agents 
such as pathogens by mounting an efficient immune 
response. It is generally characterized by a decreased 
proliferation of T lymphocytes and an impaired T-helper 
activity, which lead to impaired cell-mediated and humoral 
responses to T cell-dependent antigens. Morely et al. 
suggested that an insufficient intake of energy and protein 
distorts different components of the immune system, as 
reflected by a delayed cutaneous hypersensitivity and 
decreased total lymphocyte count, T-cell proliferation, 
and interleukins [207, 286]. In addition to the well-
recognized phenomenon of immunesenescence, aging is 
also characterized by an increase in systemic low-grade 
inflammation (“inflammaging”), which predisposes 
elderly to the development of chronic inflammatory 
diseases [287]. In summary, whereas the innate immune of 
elderly is maintained if not enhanced, aging of the immune 
system is mostly characterized by a decline in acquired 
immunity [288].
In addition to the pathogen load, the nutritional 
status is a major factor influencing T cell responses [288]. 
Evidence is accumulating suggesting that a suboptimal 
status of essential nutrients, as is the case in malnutrition, 
contributes to the immunological defects observed with 
aging. In addition to dietary lipids, the main nutrients 
involved in immune function are water-soluble vitamins 
(B6, folate, B12, C). Among the fat-soluble vitamins, the 
most convincing evidence was obtained for vitamins A, D, 
and E. These nutrients selectively influence the immune 
response and support a coordinated host response to 
infections. Deficiency may thus impact virulence of 
otherwise harmless pathogens [289]. For illustration, a 
study reported that 200 IU of vitamin E supplementation 
administered to nursing home residents significantly 
reduced the risk of upper respiratory tract infection [290]. 
Another micronutrient receiving increased attention for its 
role in host defenses is vitamin D in particular as Toll-
like receptor-mediated mechanisms appear to be most 
vulnerable to subclinical vitamin D deficiency [291]. 
Therefore, vitamin D may have particular relevance to 
frail older adults with limited exposure to the sun and who 
do not receive supplementation. Of note, an increased 
intake of some of these nutrients above the recommended 
levels even appears to be needed to maintain a proper 
function of the immune system and to reduce the incidence 
of infections in the elderly [288, 292].
Trace elements found in the diet and involved in 
immune function, such as selenium, zinc, copper, and 
iron, should also be considered. For illustration, a recent 
study involving nursing home residents found that subjects 
with low zinc concentrations had a lower incidence of 
pneumonia, a shorter duration of pneumonia, and fewer 
days of antibiotic use than did those with normal zinc 
serum concentrations [293].
The immune system is influenced by dietary 
lipids that are precursors of eicosanoids, prostaglandins, 
and leukotrienes. Lipids may thus also have important 
Oncotarget13875www.impactjournals.com/oncotarget
immunomodulatory effects, especially PUFAs, which 
regulate the inflammatory process and the immune 
response [294]. As discussed earlier in Section 3.1 devoted 
to the nervous system, an increased intake of n-3 PUFAs 
is recommended to prevent and ameliorate inflammatory 
and autoimmune diseases as well as several age-related 
diseases in which inflammation plays a role. However, 
as for pharmacology, the complex nature of immunity 
cautions against a general “one-fits-all” recommendation 
and a proper balance between the immune response and 
inflammation must be achieved, even for the identification 
of dietary solutions.
Malnutrition in the elderly is not only associated 
with a diminished immune response to pathogens but 
also with an impaired response to vaccines. In elderly, 
especially those in nursing homes, malnutrition indeed 
appears to impair vaccine efficacy due to an adequate 
immune response [295]. Three vaccines including 
influenza vaccine, pneumococcal polysaccharide vaccine, 
and herpes zoster vaccine, are specifically recommended 
by the Centers for Disease Control and Prevention for 
adults over 65 y of age [296].
Skin system
Nutrient deficiencies or malnutrition can have 
negative effects on wound healing by prolonging the 
inflammatory phase, decreasing fibroblast proliferation, 
and altering collagen synthesis [297]. Malnutrition has 
also been related to a decreased wound tensile strength 
and increased infection rates [298]. Malnourished patients 
can develop pressure ulcers and infections that delay 
wound healing and result in chronic non-healing wounds. 
Chronic wounds represent a significant cause of morbidity 
and mortality for many elderly patients.
Malnutrition increases the risk for the occurrence of 
pressure sores. Low protein and energy intake, a low BMI, 
and albuminemia are risk factors for the development of 
pressure sores in the elderly [299]. A meta-analysis of four 
clinical studies showed that oral nutritional supplements 
could significantly reduce the incidence of pressure 
ulcer development in at-risk patients with an odds ratio 
of 0.75 [300]. On the other hand, data on the effect of 
the nutritional status of elderly on the healing of existing 
pressure ulcers is scarce and not entirely convincing. 
However, the existing data suggests that malnutrition 
slows down the healing process and that an increase in 
protein and energy intake increases the rate of healing. 
Overall, the consensus is that nutrition is important for 
wound healing [300].
Well-being, overall health, and mortality
The impact of malnutrition on the well-being of 
elderly has not been studied systematically until recently. 
A pooled analysis of fifteen studies reporting an association 
between the nutritional status of elderly and their quality 
of life concluded that the overall (physical) quality of life 
was almost threefold better in well-nourished participants 
compared to individuals with malnutrition (OR: 2.85; 95% 
CI: 2.20–3.70) [301].
Numerous studies in acute-care hospital settings 
have demonstrated a strong inverse association between 
specific clinical markers of the protein-energy nutritional 
status and the risk of morbidity and mortality [45, 302]. 
Other studies examined the association between 
the nutritional status and clinical outcomes during 
hospitalization or after hospital discharge [303, 304]. 
Malnourished elderly and elderly at nutritional risk tend 
to have longer hospital stays, delayed wound healing, 
higher incidence of complications, higher re-admission 
rates, and higher mortality rates, when compared to their 
well-nourished counterparts [45, 305]. For illustration, 
severely malnourished hospitalized elderly patients were 
more likely than well-nourished patients to be dependent 
in their daily activities three months after discharge. 
They were also more likely to spend time in a nursing 
home during the first year after discharge [299, 303]. In 
185 elderly hospitalized patients, a low energy intake 
was an independent risk factor for nosocomial infections 
[15, 306, 307]. Finally, episodes of sepsis occurred 
significantly more often in severely undernourished 
hospitalized elderly patients [308].
An association between mortality and malnutrition 
or nutritional risk has been consistently reported in 
elderly subjects as assessed by BMI, weight loss, plasma 
levels of albumin, and food intake [45, 309]. Several 
prospective studies performed in the community showed 
that weight loss and a lower dietary intake, as measures of 
nutritional risk, were associated with increased mortality, 
independently of the health status. One study reported an 
increased risk (RR = 2) for mortality when comparing 
weight losers and elderly with a stable weight [310]. 
Another study with 288 elderly showed that weight loss 
was a significant predictor of mortality with a RR of 
1.76 [304]. Other indicators of malnutrition or nutritional 
risk, including serum albumin and variables related to 
inflammation, showed a mortality RR of 2.3. A significant 
RR for mortality of 3.7 was also measured among elderly 
women with low serum albumin levels, a significant 
RR of 1.9 being observed for men [299]. In hospital 
settings, mortality doubled in the most underweight 
elderly (BMI < 18 kg/m2) compared to subjects with 
a BMI ranging between 20 and 40 kg/m2. In patients 
aged 70–79 y, mortality even tripled in the patients with 
BMI < 18 kg/m2 compared to the patients with a BMI 
ranging between 32 and 40 kg/m2 [308]. This data suggests 
that aging increases the risk of mortality in severely 
underweighted patients. In addition, weight loss was the 
best predictor of mortality one year after admission and 
hospital discharge [311]. During acute hospitalization both 
age and albumin were significant predictors of mortality, 
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low albumin levels on admission being associated with 
a relative risk of death of 3.7 [312]. Finally, a group of 
elderly with low nutrient intake had a dramatically higher 
rate of in-hospital mortality (RR = 8.0) and 90-day 
mortality (RR = 2.9) compared to the control [302]. Taken 
together, an inverse correlation between the quality of the 
nutritional status and mortality is undisputed.
DIETARY SOLUTIONS FOR THE AGING 
GASTROINTESTINAL TRACT
Factors influencing nutrient requirements and 
food intake in elderly
The nutritional status in elderly is multi-factorial 
and is both influencing and influenced by the health status. 
A balanced diet with all the specific nutrient requirements, 
a physically active healthy lifestyle, avoidance of tobacco, 
and maintaining a healthy body weight are key factors to 
prevent malnutrition and chronic diseases and keep older 
adults healthy, independent, and community dwelling 
[313]. When a risk of malnutrition is diagnosed, it is 
essential to combine a nutritional support with measures 
for the identification and correction of risk factors [314]. 
Health-promoting interventions implemented individually, 
such as exercise programs, preventive home visits, 
comprehensive geriatric evaluation and management, and 
attention to adequate nutrition with or without nutritional 
supplements, have been shown in separate studies to 
be both feasible and effective in reducing age-related 
deterioration [315].
The complex set of functional changes taking 
place along the GIT, described in Part 2 of this review, 
which preterits an efficient distribution of nutrients to 
the organism of elderly, and the dramatic impact of 
malnutrition on the health status of elderly, highlighted in 
Part 3, underline that dietary solutions aimed at preventing 
and treating malnutrition in elderly must be developed 
based on an understanding of the factors influencing 
nutrient requirement, food intake, and the capacity of the 
senescent GIT to extract nutrients from the food matrix 
and to absorb them.
Dietary guidelines against malnutrition in 
the elderly
General dietary recommendations for older adults 
are addressed in Dietary Reference Intakes (DRIs) in 
the USA [316], considering age categories 51 y to 70 y 
and > 70 y. The European Food Safety Authority (EFSA) 
established Dietary Reference Values (DRV) for total 
carbohydrates and dietary fiber [317], fats [318], water 
[319], and protein [320] for the European population. 
In 2013, the EFSA reviewed energy recommendations, 
considering age categories of 60–69 y and 70–79 y [321]. 
Revision of DRVs for micronutrients is ongoing [322] but 
the existing recommendations do not yet consider specific 
amounts for older adults. The current guidelines are thus 
merely indicators since actual nutrient requirements 
depend on all the factors listed on the previous sections.
More specific recommendations to prevent and 
deal with malnutrition in elderly have been addressed by 
several health authorities and reviews. To reduce risk of 
protein-energy wasting and frailty in Europe, a daily intake 
of 30–40 kcal/kg and 1.0–1.5 g protein/kg body weight 
was proposed, whereas the exact recommended values 
depend on the health status [314, 323, 324]. In the USA, 
the Academy of Nutrition and Dietetics suggested a range 
of daily protein intake between 1.0 and 1.6 g/kg, with a 
consumption of 25–30 g of high quality protein at each meal 
[313]. Protein pulse feeding and the consumption of fast 
proteins (such as whey protein) may promote muscle protein 
synthesis and prevent sarcopenia in older adults [323, 325].
Several reviews described that older adults are at 
higher risk of vitamin and mineral deficiencies, although 
their energy intake is within recommendations, particularly 
vitamins A, B1, B2, B12, D, E, K, calcium, and potassium 
[313, 326, 327]. However, the recommendation remains 
still valid: older adults should meet the micronutrient 
requirements determined for adults by consuming a 
balanced diet and micronutrient supplements should 
only be used when food intake is too low. Neither the 
European Commission nor the American Academy of 
Nutrition and Dietetics has suggested a beneficial effect 
of higher micronutrient reference values for older adults. 
Furthermore, both have stressed the importance of 
following the Mediterranean Diet as a whole diet approach 
to promote healthy aging [313, 328].
Strategies with oral nutritional support are important 
to deal with established malnutrition or with individuals 
at risk of malnutrition. In this context, the first step should 
be dietary modifications to increase the intake of protein 
and energy from food, while preserving the enjoyment of 
eating. Oral nutrition supplements (ONS) may be used 
as adjuncts to the nutritional management. The main 
measures to increase protein and energy intake include 
[314, 329, 330]: 1) increasing eating frequency with at least 
three meals a day and snacks between meals, 2) increasing 
nutrient density of meals by enriching traditional foods 
with milk powder, whole milk concentrate, grated 
cheese, eggs, fresh cream, and nuts, 3) using fortified 
foods like enriched bread, yogurt, or pasta, 4) drinking 
nourishing fluids such as milk drinks, smoothies, and 
juices, 5) prescribing ONS in specific diseases related 
to malnutrition, eaten as snacks, or added to meals, and 
6) developing foods with textures that are adapted to the 
oral health of elderly consumers.
Needs for nutrition monitoring
With increasing prevalence of malnutrition among 
older adults, performing nutritional screening of elderly on 
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a regular basis for the detection of malnutrition risks and 
early implementation of adequate action plans is essential. 
These measures will enable older adults to maintain their 
independence and life in community settings for longer 
periods and to decrease morbidity and mortality risks 
associated with malnutrition. Acute diseases are regularly 
associated with decreased food intake and low physical 
activity both leading to muscle mass loss, especially in 
older people. Furthermore, malnourished patients tend to 
have longer hospitalization times and are more susceptible 
to infections [331] (see also Part 3). Assessing the risk 
of malnutrition and implementing a nutritional support 
during hospital stays is thus essential, along with an 
adequate rehabilitation program, in order to prevent loss 
in lean body mass [332]. Finally, nutritional interventions 
should be continued after discharge from the hospital to 
maintain independence [333].
The screening of malnutrition must be carried out 
by primary care doctors at least once a year in general 
practice and on admission to care homes and hospital 
[314]. Clinical decision making and implementation of 
nutritional support relies on objective classification of a 
patient state, i.e. at risk of malnutrition, malnourished or 
severely malnourished. Simple, validated, and reliable 
screening tools should be used, as already described in 
Section 1.3.2. However, as different screening tools may 
lead to different diagnosis, the assessment instrument 
must be standardized and used in all screening situations. 
With appropriate adjustment of the cut-off point for 
different populations, the MNA and MNA-SF have been 
extensively used and validated worldwide [334]. The 
MNA also appears to be the most appropriate tool for 
nutritional assessment of the elderly living in their homes 
[335]. If possible, a self-MNA may be used, being even 
more sensitive and specific in identification of malnutrition 
when completed by the elderly instead of the caregivers or 
a health care professionals [336].
Treatment of malnutrition should involve a 
multidisciplinary team including geriatricians, dietitians, 
caregivers, and other health professionals when necessary. 
It should be based on treatment of the underlying cause 
of malnutrition and on improvement of the nutritional 
status, the nutritional intervention lasting at least three 
months [333]. Training, communication, and coordination 
of nutritional intervention and monitoring between 
health care professionals in hospital, the community, 
and caregivers are also essential. Routine monitoring 
of weight changes, re-evaluation of malnutrition risks, 
and estimation of food intake are key aspects to assess 
effects of intervention [314, 333, 334]. Food diaries kept 
by independent elderly at risk of malnutrition may also 
be useful to assess nutrient intake and to follow up the 
implemented dietary plans [337]. Nutritional management 
may be complemented by devices developed specifically 
for autonomous elderly. In that regard, pilot studies with 
telemedical systems [338] and ambient intelligent systems 
[339] have shown that these devices may promote a more 
effective nutritional management. Although the elderly 
users defined these systems as easy to use and appreciated 
the offering of menus, 50% of them stated that they do 
not want to be controlled and surrounded by technology, 
pointing to limitations in the implementation of these 
devices [339].
Impact of major food products on malnutrition
The food products building a balanced and correct 
human diet already contain the nutrients necessary to 
satisfy the nutritional needs of healthy adults and could 
significantly counteract the negative effect of malnutrition 
in elderly. Section 4.4 describes the evidence available 
for the effectiveness of five major food groups, i.e. dairy 
products, meat products, fish, cereal-based foods, and 
fruits and vegetables. Nevertheless, in addition to 
differences in the nutritional needs, the functionality of the 
GIT and in the food choices should be carefully considered 
in the formulation and manufacturing of products 
specifically devoted to elderly. Such a strategy could 
represent an important step ahead in the counteraction of 
malnutrition in aged people.
Dairy products: proteins, calcium, vitamins, 
and bacteria
The impact of the ingestion of a range of dairy 
products on an equally broad range of health-related 
parameters in elderly subjects has been investigated quite 
intensively in observational and interventional studies. 
Regarding the overall nutritional status, an increased 
consumption of dairy products in elderly correlated with 
increased intake of energy, protein, vitamins (A, B2, 
B5, B9, B12), minerals (calcium, magnesium, zinc, 
phosphorus), and cholesterol [340–346]. Further, some 
important nutrients, in particular vitamin B9 [345] and 
vitamin D [346], can be delivered to consumers by 
fortifying milk.
The ability of dairy products to positively 
influence the immune system is the health benefit mostly 
reported for these products in elderly. Most of the 
evidence was obtained with dairy products containing 
bacteria, in particular milk fermented to yogurt in the 
presence of probiotic strains and/or lactic acid bacteria. 
A positive effect has been shown in a range of clinical 
indications, such as common cold [347], infectious 
diseases of the airways including upper respiratory tract 
infections and rhinopharyngitis [348, 349], common 
infections in hospitalized patients [340], and infections 
with Clostridium difficile [350]. In addition, an anti-
inflammatory activity mediated by products of milk 
fermentation was identified after consumption of a 
probiotic yogurt [351], accompanied by a decrease in 
mutagenicity in the intestinal tract [352]. Dairy products 
were also reported to strengthen vaccination protocols as 
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shown for influenza vaccination [353, 354]. Another study 
provided evidence for an immunological contribution 
of non-bacterial components of dairy products as whey 
proteins enhanced the serum response of elderly to 
pneumococcal vaccine [355]. Taken together, dairy 
products can be considered as strategic food vectors 
to deliver immunomodulatory components to elderly 
helping them to strengthen their immune system. Clearly, 
these findings must be discussed in the context of the 
important role of the human gut microbiota on the immune 
system and of the role of nutrition in modulating these 
interactions [356].
Milk is a key food to sustain bone health, a 
property that is primarily mediated by calcium, inorganic 
phosphate, vitamin D, and proteins [357]. A significant 
positive correlation was observed between dairy nutrient 
consumption and bone mineral density at the total hip 
and femoral neck in elderly men, but not in elderly 
women [358]. Vitamin D-fortified milk also supported 
the management of hypovitaminosis by increasing 
25(OH)D
3
 and calcium levels [346]. Also, vitamin D 
and calcium-fortified soft plain cheese appeared, at least 
transiently, to reduce secondary hyperparathyroidism and 
bone remodeling by decreasing parathyroid hormone 
and increasing insulin-like growth factor-I (IGF-I) and 
the bone formation marker P1NP [359]. Another study 
reported that vitamin D in vitamin D-fortified cheese is 
bioavailable in both young and older adults although this 
product was insufficient to increase serum 25(OH)D
3
 
during limited sunlight exposure [360]. In women having 
experienced a recent hip fracture, casein and whey proteins 
combined with essential amino acids both induced a 
significant elevation of serum IGF-I [361]. Finally, milk 
intake positively correlated with serum IGF-I levels in a 
study involving postmenopausal women enrolled in the 
Women’s Health Initiative [362]. Supplementation of 
a product composed of essential amino acids and whey 
proteins with zinc accelerated the serum IGF-I response of 
elderly to the whey protein while decreasing a biochemical 
marker of bone resorption [363]. In that context, the 
European Society for Clinical and Economic Aspects of 
Osteoporosis and Osteoarthritis (ESCEO) recommended 
the daily consumption of calcium- and vitamin D-fortified 
food products (e.g. yogurt or milk) by fragile elderly 
subjects at elevated risk for falls and fracture [364]. Taken 
together, calcium and proteins in milk, supplemented with 
vitamins and minerals, in particular vitamin D, mitigate 
the development of osteoporosis in the elderly.
Dairy products also support muscle health by 
delivering BCAAs to the aging organism. Milk proteins are 
rich in the BCAAs leucine, isoleucine, and valine, which, 
in particular leucine, are required for optimal stimulation 
of the rate of muscle protein synthesis in the elderly 
[365], thus preventing age-related sarcopenia. In older 
men, milk-derived whey proteins stimulated postprandial 
muscle protein accretion more effectively than caseins. 
This effect was attributed to the kinetics of digestion 
and, consequently, intestinal adsorption of whey proteins, 
which are fastly absorbed compared to the slow caseins. In 
addition, whey proteins are characterized by a high content 
of leucine, which further contributes to improving muscle 
mass [255]. A study evaluating the association of dairy 
intake with body composition and physical performance 
in older women revealed significantly greater whole body 
lean mass and appendicular skeletal muscle mass, greater 
handgrip strength, and lower odds for a poor Timed Up 
and Go (TUG) motility test. However, the difference 
in prevalence of falls was not statistically significant 
[366]. Although milk protein supplementation combined 
with low intensity physical exercise in older people 
suffering from polymyalgia rheumatic tended to prevent 
accumulation of body fat, it did not result in significant 
and consistent difference in the changes of muscle mass 
indices or muscle functions [367]. Finally, milk proteins 
(casein and whey) have been used as therapeutic modality 
to conserve muscle mass in chronic wasting diseases such 
as chronic obstructive pulmonary disease [368, 369].
Other common health problems in elderly may be 
ameliorated by consumption of dairy products. Yogurt 
supplemented with dietary fiber relieved constipation 
[370, 371] and intake of probiotic fermented milk 
alleviated symptoms of non-viral gastroenteritis [372]. 
Dental health may be improved by consumption of 
milk supplemented with fluoride and probiotics [373]. 
Finally, consumption of yogurt was associated with a 
lower common carotid artery intima-media thickness in 
a cohort of Australian elderly subjects [374], suggesting a 
beneficial effect in CVD risk.
Of note, since the food habits of many elderly 
people are inadequate, flavor amplification might induce 
changes in preferences for the consumption of food. Dairy 
products such as yogurt thus provide an interesting matrix 
to introduce flavors preferred by elderly in order to more 
efficiently deliver nutrients tailored to their nutritional 
needs [375].
Meat products: proteins, iron, vitamin B12, 
and carnosine
Although not strictly necessary in the human 
diet, meat shows considerable nutritional properties, 
including a good balance in indispensable amino acids 
(IAA), and high levels of B vitamins and minerals thus 
becoming an important component of a balanced diet. In 
moderate amounts, and combined with other foods being 
part of a healthy diet (vegetables, starches, fruits, dairy 
products), meat is useful to prevent possible deficiencies 
in vitamin B12, iron, zinc, and selenium [376].
In contrast to the general belief of elderly, their 
protein requirement is not decreased, but rather increased, 
despite a general decrease in their physical activity [377]. 
Although meat could efficiently cover their protein 
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requirement, elderly tend to significantly decrease its 
consumption for multiple reasons (loss of sense of smell 
and taste, chewing difficulties…). In light of the ability 
of meat to efficiently deliver IAA, efforts should be made 
to develop meat products with adapted texture, taste, and 
digestibility to make them more attractive for the elderly.
Mainly in the form of heme iron, meat iron has a 
greater bioavailability than non-heme iron of plants or 
dairy products [378]. Also, heme iron absorption, in 
contrast to non-heme iron, is largely uninfluenced by other 
dietary constituents. In addition, meat enhances non-heme 
iron absorption [379]. Thereby, vegetarian populations 
in comparison to omnivore populations are generally 
characterized by a lower plasmatic concentration of 
ferritin, which is indicative for reduced iron stores [380]. 
Furthermore, ruminant meat is an important source of 
vitamin B12. In ruminants, this vitamin, which is strictly 
of microbial origin, is synthesized in the rumen before 
being absorbed and stored in the liver and in muscle. For 
this reason, the vitamin B12 level in ruminant meat is 
higher than that measured in meat from pork and chicken. 
Based on average beef consumption, ruminant meat is 
considered to cover approximately two thirds of the daily 
intake of vitamin B12 in humans. In addition, the chemical 
forms of vitamin B12 present in meat are the biologically 
active forms. This is, for example, not the case for 
sea foods, which contain high levels of biologically 
inactive forms of vitamin B12 [381]. An insufficient 
meat consumption may thus increase the risk of iron 
and vitamin B12 (sub-) deficiency in humans leading to 
anemia. It should finally be noted that both heme-iron and 
vitamin B12 concentrations in meat, can be significantly 
affected by the technological processes involved in meat 
preparation [382, 383].
A major feature of aging is the progressive decline 
in muscle mass, leading to sarcopenia. At an advanced 
stage, aging causes frailty and a progressive loss of 
autonomy of the individual. Associated with maintaining 
regular physical activity, protein nutrition can slow down 
the development of aging. The mechanisms involved in 
the development of sarcopenia are multiple and multi-
factorial, but all of them result in an imbalance between 
the synthesis and degradation of muscle protein. This 
imbalance may be partly explained by a decrease in 
anabolic response related to food intake. Indeed, in the 
elderly, the installation of an ‘anabolic resistance’ to the 
effects of nutrients and hormones translates into a higher 
threshold of stimulation of the muscle protein anabolism 
[384]. Noteworthy, it is still possible to trigger protein 
anabolism in elderly, but with a higher intake of stimuli. 
Thus, in order to recover, or at least improve, postprandial 
muscle anabolism in the elderly, it is necessary either to 
restore the protein metabolism sensitivity to postprandial 
signals, and therefore to lower the stimulation threshold, 
or to optimize the postprandial kinetics of amino acids 
absorption, so as to exceed the stimulation threshold. For 
the latter option, two nutritional strategies are possible 
without increasing the overall protein intake, namely 
concentrating daily protein intake in one meal [325, 385] 
or using rapidly digested proteins [386]. Because of its 
high density in protein, rich in IAA, and because it is 
rapidly digested in healthy elderly [95], meat is a good 
candidate for the implementation of both strategies. 
Recent work highlights the importance of meat in the 
diet of older people to boost muscle protein synthesis 
[387]. At equivalent amounts of protein, meat was more 
effective than a source of vegetable protein, such as 
soybeans, which is rather well balanced in IAA [388]. 
However, a significant reduction in masticatory efficiency, 
accompanied by a swallowing of less disintegrated pieces 
of meat, as frequently observed in advanced age, could 
compromise its strengths in elderly nutrition. Indeed, 
edentulous subjects wearing complete dentures had a 
significantly reduced protein digestion rate and, possibly, 
digestibility in the small intestine. This has harmful 
consequences for the elderly as this phenomenon is 
accompanied by a lower utilization of meat-derived amino 
acids for the synthesis of body proteins [95]. However, 
the technological processing of meat (mincing, cooking 
conditions) could significantly affect meat protein 
digestion rate, and protein assimilation [389, 390], and 
thus offer solutions to counteract the chewing inefficiency 
problems.
Carnosine (β-alanine-L-histidine) and anserine 
(β-alanine-L-1-methyl-histidine) are histidine-containing 
dipeptides (HDP) present exclusively in animal tissues. 
They are particularly abundant in the skeletal muscle 
of mammals, and thus in meat. Their total amount and 
proportion may vary from one species to another as 
well as between muscles. Their concentration in meat is 
generally only moderately affected by the technological 
processes [391]. Besides their buffering capacity, HDP 
also have antioxidant properties towards proteins and 
nucleic acids, in particular because of their capacity to 
bind divalent metal ions and trap free radicals. Moreover, 
HDP appear to reduce aldehydes formed from unsaturated 
fatty acids during oxidative stress [392]. They may also 
have a major role in protection against protein glycation 
and crosslinking [393]. The crosslink of proteins interferes 
with their tissue function and may lead to aggregation 
of cell material in the form of plates. Thus HDP could 
play an important role in the prevention of secondary 
diabetic complications [394] and in the protection against 
neurodegenerative disorders such as Alzheimer’s disease 
[395]. Because of these antioxidant properties, diets rich 
in HDP, in particular meat products, may be beneficial 
for the elderly [396]. In that regard, a recent study with 
HDP supplementation in elderly showed promising effect 
on cognitive functioning [397], with a dose of HDP 
corresponding to about two meat portions of 120 g/d.
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Fish: polyunsaturated fatty acids and selenium
Although fish consumption has not been directly 
used for treatment or prevention of malnutrition, it has 
been associated with protection of several diseases in 
elderly, which may either be risk factors or consequences 
of malnutrition. Health effects of fish consumption have 
been attributed to the anti-inflammatory properties of n-3 
LC-PUFAs, in particular EPA and DHA, which are present 
in high amounts in oily fish [398]. In the majority of 
nutritional cohorts investigating the relationship between 
fish consumption and cognitive function, consumption of 
one portion of fish per week was associated with a reduced 
risk for cognitive deterioration, either through association 
with a healthy eating pattern or through a direct impact of 
fish consumption [399, 400]. However, elderly consume 
insufficient amounts of fish and malnourished elderly 
tend to consume fatty fishes of poor nutritional quality. 
Nevertheless, the health effects of fish might involve a 
synergistic effect between selenium and n-3 LC-PUFAs 
[401]. For over a decade, studies have shown an inverse 
association of fish consumption with cognitive decline and 
the development of neurodegenerative diseases in older 
adults [402–405]. Baierle and collaborators reported that 
higher plasma levels of total long chain n-3 fatty acids and 
DHA, and lower levels of saturated fatty acids, were related 
to a better cognitive performance in older adults [405]. 
Studies with fish oil or EPA and DHA supplementation 
have shown memory improvement in elderly with mild 
cognitive impairment [406, 407]. Other studies with elderly 
reported that fish consumption reduces CVD markers 
[405, 408], lowers risk of hip fractures [409], improves 
kidney function [410], and alleviates depression symptoms 
[411]. Regarding GIT dysfunction in aging, an inverse 
relation of periodontal disease progression with dietary 
DHA intake has been reported in Niigata citizens [412].
Plasma levels of EPA and DHA are positively 
associated with fish frequency consumption in older 
people [413]. However, the authors observed that the 
increase in DHA levels with fish consumption was lower 
in elderly with APOE4 genotype (main genetic risk factor 
for Alzheimer’s disease characterized by a reduced activity 
of lipoprotein lipase and increased oxidative stress). These 
results suggest that bioavailability of n-3 LC-PUFAs may 
be affected by genetic factors and that this issue must 
be addressed when designing foods enriched in these 
fatty acids.
Cereal-based foods: carbohydrates and dietary fiber
Carbohydrates have special significance in cereals, 
which usually comprise about 50–80% carbohydrate on 
a dry weight basis [414]. Starch is the most abundant 
cereal polysaccharide being an important energy source 
in human diets. There are two types of carbohydrates: 
available carbohydrates, such as starch and soluble 
sugars, are digested and absorbed by humans, whereas 
unavailable carbohydrates (dietary fiber), such as resistant 
starch, cellulose, and other complex polysaccharides 
(β-glucan, pectins, arabinoxylans…), are not digested by 
the human GIT.
In 2010, the EFSA established an adequate intake 
of dietary fiber of 25 g per day for normal laxation in 
adults based on the role of dietary fiber in bowel function 
[317]. Moreover, the EFSA approved several health claims 
related to the consumption of dietary fiber: 1) arabinoxylan 
contributes to a reduction in postprandial blood glucose, 
2) barley grain fiber, oat grain fiber, and sugar beet fiber 
contribute to an increase in faecal bulk, 3) wheat bran 
fiber contributes to an acceleration of intestinal transit and 
increases faecal bulk [415, 416]. Of note, these claims can 
only be used for foods that are enriched in the particular 
dietary fiber referred to in the claims. Also, “high fiber”, 
as listed in the Annex to Regulation (EC) No 1924/2006, 
indicates that the product contains at least 6 g of fiber per 
100 g or at least 3 g of fiber per 100 kcal. In the USA, the 
Food and Drug Administration (FDA) has approved two 
health claims for dietary fiber. The first claim states that, 
along with a decreased consumption of fats (< 30% of 
calories), an increased consumption of dietary fiber 
from fruits, vegetables, and whole grains may reduce 
some types of cancer [417]. “Increased consumption” 
is defined as ≥ 1 “ounce equivalent” (1 ounce = 28.3 g), 
with three ounces derived from whole grains. A one 
ounce equivalent would be consistent with one slice of 
bread, ½ cup oatmeal or rice (1 cup = 237 ml), or five to 
seven crackers. The second FDA claim supporting health 
benefits of dietary fiber states that diets low in saturated 
fat (< 10% of calories) and cholesterol as well as high in 
fruits, vegetables, and whole grain, decrease the risk of 
coronary heart disease [418]. In summary, an healthy diet 
should be composed of 25–35 g dietary fiber per day, of 
which 6 g should be soluble fiber [419]
During the last decades, epidemiological and clinical 
studies demonstrated that consumption of dietary fiber and 
whole grain has a positive impact against obesity [420], type 
2 diabetes [421], cancer [422], and CVD [423] in middle 
aged people. In 535 healthy elderly, aged 60–98 y, diets 
rich in whole-grain foods appeared to delay the onset of the 
metabolic syndrome [424]. In a recent study with mature 
women (50–72 y) the intake of a diet rich in fiber (43–47 g/d) 
during 4 weeks decreased serum total cholesterol, LDL-
cholesterol, and to a lower extent, HDL-cholesterol [425]. 
The mechanism of action of the beneficial effects of dietary 
fiber and the bioactive components mediating these effects 
are still unclear. Among these, the protective effects of 
short-chain fatty acids, such as propionate, obtained by the 
fermentation of dietary fiber in the gut [426], an increased 
rate of bile excretion reducing serum cholesterol [427], 
and a decrease in pro-inflammatory mediators, such as 
interleukin-18 (IL-18) and C-reactive protein (CRP) 
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[428, 429], should be highlighted. In summary, data on the 
impact of dietary fiber on the health of elderly are scarce 
or, even, non-existent regarding the specific needs of 
malnourished elderly.
Within cereal products, bread is one of the most 
popular food products. It is part of a majority of diets 
consumed around the world although bread products 
and their preparation techniques vary widely [430]. The 
basic ingredients are cereal flour, water, yeast or other 
fermentative agents, and salt [431]. However, optional 
ingredients can be added to improve processing or to 
produce speciality and novelty breads, which often have 
an increased nutritional value. Bread provides essential 
nutrients such as carbohydrates, B vitamins (B1, B2, 
B3, B6, B9) and minerals (phosphorus, potassium, 
magnesium). Due to these nutritional properties, nutrition 
experts define bread as an essential constituent of the 
food pyramid. In countries where bread is a staple source 
of carbohydrates, it does indeed constitute the base of 
the diet [432].
Fruits and vegetables: phytochemicals
Although increasing evidence on the health effects 
of phytochemical compounds, particularly polyphenols, 
has been accumulating for several years, studies with 
older adults are scarce. Inflammation plays a critical role 
in the aging process and associated degenerative diseases. 
Thus, the anti-inflammatory properties of phytochemical 
compounds are the basis of their beneficial effects on 
healthy aging [433].
There were few controlled trials studying the impact 
of consumption of food rich in polyphenols exclusively 
in the elderly for periods of at least 8 weeks. Most of the 
studies focused on improvement of cognitive function as 
a form of prevention or treatment of dementias, which 
are diseases with increasing prevalence among elderly 
and one of the risk factors for malnutrition. Several 
polyphenols or foods enriched in polyphenols have shown 
improvements in cognition including flavonoid rich cocoa 
based drink [434], concord grape juice [435], resveratrol 
[436], and Gingko biloba [437]. Polyphenols have also 
potential benefits against other diseases associated with 
malnutrition, such as catechins from green tea extract 
against sarcopenia [438] and polyphenol-rich chocolate 
against chronic fatigue syndrome [439]. Red wine (alcohol 
free) ingestion seemed to facilitate the swallowing reflex 
in elderly patients with dysphasia, a pathology associated 
with GIT dysfunction [440].
Some studies with postmenopausal women 
addressed the effect of isoflavone consumption in the 
prevention of osteoporosis. It seems that isoflavone 
supplementation has, on its own, no effect in preventing 
BMD decline [441]. However, when supplemented with 
vitamin D, vitamin K1, and PUFAs, isoflavone maintained 
BMD and increased bone-specific alkaline phosphatase 
[442]. A recent review has also suggested that flavonoids 
protect against bone loss by promoting osteoblast function 
and reducing chronic low-grade inflammation [443].
Assessing their bioaccessibility and bioavailability 
will be a key issue to validate the use of bioactive 
phytochemical compounds to fortify foods for elderly. 
In particular, a large variability in these parameters may 
arise from digestion impairment, changes in microbiota 
composition, and polymorphisms in phase II enzymes 
[444]. Another important issue is the impact of food 
processing on the bioaccessibility and bioavailability 
of polyphenols. For example, quercetin in cereal bars 
seems to be more bioavailable than in powder filled 
capsules [445].
Water
Elderly are more vulnerable to water imbalance 
and many of them do not reach their recommended daily 
intake of oral fluids [446]. Anorexia and malnutrition 
tend to worsen fluids intake due to decreased appetite 
and decline in the motivation to eat or drink. In addition, 
higher thirst thresholds [447] and adverse effects of drugs, 
such as diuretics, also contribute to dehydration [448].
In the absence of fluid intake death occurs in a 
few days to a week, thus far more quickly than in the 
absence of any other nutrient [449]. Suboptimal hydration 
in elderly is associated with increased susceptibility to 
urinary tract infections, pneumonia, pressure ulcers, 
confusion and disorientation, whereas adequate hydration 
is associated with fewer falls, lower rates of constipation, 
better rehabilitation outcomes in orthopedic patients, and 
reduced risk of bladder cancer in men [450].
The best preventive measure to reduce dehydration 
risk in elderly is to ensure that the elderly person has a 
fluid intake of at least 1.7 L in a period of 24 h, with an 
additional intake of 500 mL per degree above 38°C when 
fever is present [451]. Several strategies to increase fluid 
intake in elderly have been recently reviewed, however, 
most failed to be conclusive [9]. When hospitalized or 
residing in care homes, the most efficacious measures 
seem to be encouragement and assistance from staff 
to drink more liquids during meals, between meals, 
and when taking medication. Elderly with dysphasia 
problems should be given thickened drinks. Availability 
of beverages and greater choice is also an important factor 
to increase fluid intake in elderly [9]. Adequate choices 
include mineral drinks, fruit and vegetable juices, milk, 
and sport drinks [451]. Independent elderly living at home 
should be provided with counseling on the amount of fluid 
intake and the best choices of drinks.
CONCLUSIONS
A wealth of information is available on the aging 
process and on the consequences of this process on the 
functionality of the organ systems in humans. Interestingly, 
although malnutrition is recognized as an important 
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morbidity factor in the elderly, this phenomenon has not 
been systematically analyzed in the context of the aging GIT. 
The major deficiencies in nutrients that are associated with 
malnutrition have been already identified (energy, amino 
acids, vitamins, minerals…) and dietary recommendations, 
including recommendations for the consumption of a range 
of major food groups covering most of the macronutrients 
and micronutrients needed by elderly populations, are 
already available from institutional bodies, thus contributing 
to limiting the impact of malnutrition on the health status of 
elderly. These efforts are, however, far from having reached 
their promises, not the less because the knowledge covering 
the efficiency of the delivery, by the aging GIT, of nutrients 
to the organism has not be integrated neither into the health 
status of the elderly nor into the formulation of new foods 
tailored on the elderly. Consequently, guidelines proposing 
optimal diets for elderly populations are as good as the 
heterogeneity of the malnutrition status of the populations 
and individuals that they target.
A new paradigm must therefore be developed in 
order to more efficiently prevent and treat malnutrition in 
the elderly. This review shows that most of the relevant 
mechanistic and physiological information is already 
available to move in that direction. However, each of these 
elements needs to be integrated into a global concept that 
encompasses the molecular composition of foods, the 
processing of the nutrients by the aging GIT, and the impact 
of the bioavailable nutrients on the health status, in particular 
the nutritional status of elderly. Recent breakthroughs in 
molecular analytical sciences now allow for a more efficient 
search for specific biomarkers in foods (foodomics) and 
humans (nutrigenomics). These technologies should be 
used to deliver, not only biomarkers of food intake [452], 
but, more specifically, biomarkers of food bioavailability 
reflecting the specific functional changes taking place in the 
aging GIT. In addition, the same analytical strategy should 
be used to identify biomarkers of malnutrition [453] in the 
elderly. An integrated and correlative analysis of both sets of 
biomarkers (i.e. bioavailability and malnutrition) should be 
conducted at the level of individual elderly subjects to allow 
for an early identification of decreased functionalities in their 
GIT and to more precisely identify dietary solutions able to 
restore the deficient metabolic profile associated with their 
particular nutritional status. Finally, the ability of specific 
foods to efficiently deliver nutrients to the organism should 
be screened in vitro in models of food digestion [454] that 
should be further validated to model the aging GIT. Although 
these goals are ambitious, the social and economic burden 
of malnutrition in the elderly provides sufficient motivation 
to use the information summarized in this review to start 
paving the road in that direction.
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